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1. Abstract  
Background Psychotic disorders have been estimated to range between 0.8% and 5.0% in the 
Intellectual Disabilities (ID) population.  This systematic review aims to provide the most accurate 
estimate of the prevalence of psychosis in the ID population, whilst appraising the quality of such 
literature. 
Method A systematic search was conducted of the electronic databases Medline, Embase, 
PsycINFO, and PubMed between commencement of each database and January 2016.  Articles 
which investigated rates of psychosis in adults aged ≥16 years with a mild to profound ID were 
selected for quality analysis. 
Results  Twelve articles met the predetermined criteria; five were rated as high quality and 
seven were rated as moderate quality.  An overall prevalence of psychosis was calculated at 7.1% 
(95% CI = 3.9-10.3) with a range of 0.8-17.7%.  Several methodological issues were identified as 
leading to both over- and under- estimates of psychosis in this population.  A key issue is the level 
and distribution of ID included within samples, and the denominator used to calculate prevalence.   
Conclusions     Existing evidence suggests that the prevalence of psychosis is likely to be higher 
than previously estimated; suggesting that policy makers and healthcare providers should consider 
how best to identify such individuals, so that they can access appropriate treatment.  
2. Background 
Psychotic illness has been estimated to range from 0.8-5.0% in the adult ID population (Lund, 1985; 
Deb et al. 2001; Bailey, 2007; Cooper et al. 2007a).  Prevalence rates of psychosis have also varied in 
the adult general population, with estimates ranging from 0.4-1.2% (Jenkins et al. 1997; Brugha et al. 
2005; Wittchen et al. 2011).  Hence, psychosis is thought to occur at a higher rate in the ID 
population than the general population.   
Existing literature on the prevalence of mental illness in the ID population is however known 
to be limited by methodological issues (see Smiley, 2005 for a review), making it difficult to 
generalise between studies.  Prevalence rates can vary widely depending on the size and 
representativeness of the sample; the definition of ID; and the method of case ascertainment, such 
as the type of diagnostic criteria used to determine caseness.  Specifically, general population 
nosology cannot accommodate the altered manifestation of mental illness caused by more severe 
levels of ID, leading to under-recognition of some psychiatric disorders in this population ( Cooper et 
al. 2007a).  For example, the prevalence of psychosis was found to vary across diagnostic criteria 
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applied to the same sample of adults with ID (Cooper et al. 2007b): 4.4% according to clinical 
diagnosis, 3.8% according to DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with Adults 
with Learning Disabilities/Mental Retardation), 3.4% according to the DMS-IV-TR (Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition, text revision), and 2.6% according to the ICD-10-
DCR (International Classification of Diseases, 10th edition, Diagnostic Criteria for Research).  Thus, 
any attempt at generalising findings must consider these methodological issues.  
 Furthermore, psychosis is a complex concept, particularly difficult to detect in the ID 
population.  It is characterised by positive symptoms such as hallucinations, or delusions; and 
negative symptoms such as poverty of speech or avolition.  Positive symptoms are internal 
experiences which can disrupt an individual’s perception of the world around them.  Hence, given 
the subjective nature of these experiences, they tend to be detected via self-report.  However, they 
may be conceptually too complex for most individuals with ID to report (Smiley, 2005).  
Alternatively, language which is developmentally appropriate may be mistaken as thought disorder 
(Smiley, 2005).  Negative symptoms can be easier to detect as they can be observed and reported by 
family members or carers.  However, negative symptoms are relatively non-specific and may be 
caused by numerous other factors, such as positive symptoms, side-effects of medication, 
depression, environmental under-stimulation or demoralization (American Psychiatric Association, 
2000).  Negative symptoms may also be attributed to the individual’s ID, and viewed by carers to be 
their ‘normal’ state.  Such diagnostic overshadowing may be more likely in the ID population given 
that: 1) longitudinal general population research has demonstrated a lengthy prodromal phase of 
nonspecific symptoms and increasing functional impairment, before more diagnostically specific 
positive psychotic symptoms emerge (Bechdolf et al. 2012; Bora & Murray, 2014); and 2) ID support 
services often have a high turnover, resulting in workers having limited knowledge of the individual 
they support (Mencap, 2007).  Hence, a multitude of factors can influence prevalence rates of 
psychosis.    
 
3. Aim 
The aim of this paper is to identify and systematically review studies that investigated the 
prevalence of psychosis in the adult ID population, with a view to 1) identifying the prevalence of 
psychosis within this population; and 2) appraising the quality of the studies. 
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4. Methodology 
Where possible, the methodology followed the Preferred Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) checklist (2009).  The following eligibility criteria were applied to the 
search.  
4.1 Eligibility 
Inclusion criteria 
1. Adults aged ≥16 years old with a mild to profound ID (as determined via researcher 
assessment or according to a learning disabilities service or register). 
2. Studies investigating prevalence of psychosis, where rates are reported or can be calculated. 
3. Studies where presence of psychosis is determined via clinical diagnosis, diagnostic criteria, 
screening measure or case-note review. 
4. Peer reviewed articles. 
Exclusion criteria 
1. Review articles (original studies will be included). 
2. General adult population studies (or mixed general and ID populations, where prevalence 
rates cannot be calculated for only those with ID). 
3. Childhood studies (i.e. samples consisting exclusively of those aged ≤15 years old, or child 
and adult samples where prevalence rates cannot be calculated for only those aged ≥16 
years old). 
4. Studies with samples that consist exclusively of specific disorders of ID (e.g. Down’s 
syndrome, Prader-Willi syndrome or Fragile X syndrome etc.).   
5. Studies with samples that consist exclusively of ID populations with specific disorders (e.g. 
ASD, dementia or epilepsy etc.). 
6. Studies consisting of only hospital/residential, specialist mental health or prison populations. 
7. Studies not published in the English language. 
8. Grey literature. 
 
4.2 Information sources and search strategy 
A systematic search was conducted on the electronic databases Medline, Embase, PsycINFO, and 
PubMed, from commencement of database until January 2016.  MeSH headings and terms were 
identified and used to search for the following broad areas: ‘intellectual disability’, ‘psychosis’ and 
‘prevalence studies’.  The results from these searches were combined with ‘AND’, in order to identify 
eligible studies.  Each database was first reviewed for its use of MeSH headings and searches were 
made according to these.  Terms that were not found under MeSH headings were searched as 
keywords in the title or abstract search fields.  For example, the search terms used for the database 
Medline are detailed in Table 1. Further details of the search terms used are described in Appendix 
8 
 
2.1.  The reference lists of eligible articles were then hand searched in order to identify any 
additional studies.  
 
Table 1 Medline search strategy 
Ovid MEDLINE(R) 1946 to Present 
Intellectual 
disability 
 
MeSH search terms: Intellectual Disability 
Mentally Disabled Persons 
Keyword search terms: intellec* disab* or learning disab* or mental* retard* 
or learning impair* or mental* handicap* 
Psychosis MeSH search terms: Psychosis 
Schizophrenia 
Keyword search terms: psychotic disorders or psychosis or psychoses or 
psychotic* or psychos* or schizophrenia or schizo* or 
schizoaffective or schizoaffective disorder or delusional 
disorder* 
Prevalence 
studies 
MeSH search terms: Prevalence studies 
Keyword search terms: prevalence or prevalence rate$ or morbidity 
 
4.3 Study selection   
Following removal of duplicates, eligibility of the articles was determined systematically via 
screening titles, reading abstracts and reading remaining articles in full.  Eligibility of all articles was 
determined in this manner, hence it was not necessary to contact authors for further information.      
 
4.4 Data extraction and methodological quality 
Each article was reviewed and the following information was sought: population characteristics; 
participant demographics; method of case ascertainment; and details of reported prevalence rates.  
A standardised appraisal of the quality of each study was conducted using an adapted rating tool 
designed to rate the quality of depression screening instruments for adults with ID (Hermans & 
Evenhuis, 2010).  Hence, only slight amendments were required to make it fit for purpose (altering 
the focus from depression to psychosis).  For the first criteria, a sample size of ≥30 should be less 
vulnerable to the influence of a non-standard distribution, and a sample of ≥100 should be powered 
to detect a significant effect (Field, 2013).  The second and third criteria allow judgements to be 
made about sample representativeness.  Population based-samples are most representative of the 
wider population as they attempt to identify all individuals meeting criteria within a geographical 
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location; whereas administrative samples use registers to identify participants thus excluding those 
who do not require such additional services.  For the fourth criteria, the gold standard of assessment 
is considered to be a clinical diagnosis made by a psychiatrist or psychologist according to a standard 
diagnostic system (Hermans & Evenhuis, 2010; Nordgaard et al., 2012).  The fifth criteria require a 
confidence interval to be reported, thus allowing an estimate of precision.  Criteria are listed for 
each domain and given a rating of 0, 1 or 2, allowing a total quality score ranging from 0 to 8 (Table 
2).  In line with Hermans and Evenhuis (2010) a score of ≤2 is consider to be low, 3–5 to be 
moderate, and a score of ≥6 to indicate high quality.  Each included article was reviewed by the 
author (AM) and assigned ratings according to this tool.  Low ratings reflect greater bias at the 
outcome level.  Using the prevalence rates reported in the included studies, an overall mean 
prevalence was calculated for psychotic disorders within the adult ID population.  In order to 
account for the risk of bias in this rate (i.e. from low quality studies), an overall mean prevalence of 
psychosis was also calculated using only the high quality articles (i.e. those scoring ≥6).  A correlation 
was performed in order to investigate any possible relationship between study quality and 
prevalence rate.        
 
Table 2 Quality rating criteria 
Domain Criteria Rating 
Sample size >100 2 
 30-100 1 
 <30 0 
Representativeness 
of sample 
Population based  2 
Administrative  1 
 All other 0 
Reporting of level of 
ID 
Distribution of ID reported  0/1 
Method of 
assessment 
Clinical diagnosis by a psychiatrist or psychologist based on 
standard diagnostic system 
2 
Clinical diagnosis by a psychiatrist or psychologist 1 
Other psychosis screening instrument used 1 
All other 0 
  
Report of precision 
estimate 
Conﬁdence interval is reported   0/1 
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5. Results 
Figure 1 illustrates the literature search process utilised; 1544 initially identified articles were 
reduced to 1114 following removal of duplicates.  Scanning the titles allowed a further 995 ineligible 
articles to be removed.  The abstracts of 119 articles were read, and a further 81 records were 
excluded for not meeting the criteria.  Thirty-eight papers were retrieved and read in full, allowing a 
further 26 articles to be excluded from the search (reasons for these exclusions are shown in Figure 
1).  A hand search of relevant reference lists identified one additional study, contributing to the total 
identification of 12 papers investigating the prevalence of psychosis in adults with ID.  Further details 
of the 26 excluded papers are shown in Appendix 2.2.  No systematic reviews were identified which 
investigated the rate of psychosis in the adult ID population, nor the quality of such studies.  Study 
characteristics, prevalence rates and total quality ratings are detailed in Table 3. 
5.1 Quality of included studies 
Quality scores across the five domains are detailed for each study in Appendix 2.3.  The average 
quality rating score for the 12 studies was 5.3 (SD=1.4) with a range of 4-8.  Of the 12 studies, five 
were rated as high quality (Göstason, 1985; Lund, 1985; Cooper, 1997; Deb et al. 2001; Cooper et al. 
2007b) and seven were rated as moderate quality (Salvador-Carulla et al.1998; Holden & Gitlesen, 
2003, 2004; Taylor, et al 2004; Bailey, 2007; Nettelbladt et al. 2009; Sheehan et al. 2015).  Only one 
study (Cooper et al. 2007b) received the maximum quality rating score of eight.   
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Figure 1 Flow chart of systematic literature search 
Records identified through 
database searching 
(n = 1544) 
Scre
enin
g 
Incl
ude
d 
Elig
ibili
ty 
Iden
tific
atio
n Additional records identified through other sources 
(n = 10) 
Records after duplicates removed 
(n =1114) 
Records screened 
(n =119) 
Records excluded 
(n = 82) 
Full-text articles excluded, with 
reasons 
(n = 26) 
Hospital/residential/specialist 
mental health samples (6) 
Review (5) 
Includes children (5) 
General population (5) 
Includes borderline IQ (3) 
Data reported in other 
included study (1) 
Prevalence not reported (1) 
Studies included in 
qualitative synthesis 
(n = 12) 
Full-text articles assessed 
for eligibility 
(n = 37) 
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Table 3 Summary of study characteristics, prevalence rates and quality ratings 
Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic tool Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Göstason 
(1985) 
N=132 (14,915) 
Stratified population 
based sample taken 
from census in 
Kopparberg County 
Sweden in July 1977 
Age 20-60 
Gender: males 59.1% 
Mild 56.8% 
Severe 43.2% 
Psychiatric 
interview with 
participant and 
family or staff 
member 
CPRS DSM-III Point-prevalence 
Schizophrenia, 
undifferentiated type 
0.8% 
Schizophrenia, residual 
type 2.3% 
Total schizophrenic 
disorders 3.0%* 
 
7 
Lund 
(1985) 
N=272 (302) 
Cluster sampling of 
adults registered on 
the Danish National 
Service for the 
Mentally Retarded 
(DNSMR) living in a 
county in Denmark 
Age 20-65+ 
Gender reported for 
whole sample: males 
56% 
IQ 67-52 (28.3%*) 
 IQ 51-36 (31.3%*) 
IQ 35-20 (12.5%*) 
IQ 19-0 (9.2%*) 
Unclassified 51 
(18.8%*) 
Participants 
‘examined’ and 
their parents or 
staff members 
interviewed 
The MRC-HBC and a 
schedule of 
psychiatric 
symptoms, leading 
to computerized 
psychiatric 
diagnosis 
DSM-III  Point-prevalence 
Schizophrenia 1.1%* 
Psychosis of uncertain 
type 5.5%* 
Total psychotic disorder 
6.6%  
6 
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Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic tool Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Cooper 
(1997) 
N=207 
Population-based 
learning disabilities 
register in 
Leicestershire UK 
 
Age 20-65 (m=39.2, 
SD=12.2) 
65-94 (m=73.2, 
SD=6.48) 
Gender: males 52.7% 
Level of ID not 
reported 
 
Clinical 
assessment with 
client and carer by 
psychiatrist & 
psychiatric case 
note review 
PPS-LD ICD-10 Point-prevalence 
Schizophrenia/delusional 
disorder 
20-65yrs 2.7% 
65+yrs 3.0% 
All ages 2.9%* 
6 
Salvador-
Carulla et 
al (1998) 
N=130 
Adults working in a 
vocational centre 
during Apr-May 
1992, Southern 
Spain 
Age 18-65 (m=36.1, 
SD=10.5) 
Gender: males 70.8% 
Mild 63.8% 
Moderate 26.2% 
Severe/Profound 
3.1% 
 Unspecified 6.9% 
Independent 
assessment using 
AIRP 
psychopathology 
section and 
psychiatric 
interview  
AIRP 
 
DSM-III-R Point-prevalence 
Schizophrenia 7.69% 
Psychotic disorders not 
specified 9.23% 
Delusional disorder 
0.77% 
Total psychotic disorders 
17.7% 
5 
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Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic tool Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Deb et al 
(2001) 
N=90 
Social services case 
register in Vale of 
Glamorgan, UK  
Age 16-64  
(m=37.7, SD=13.5) 
Gender: males 52.2% 
Mild 53.3% 
Moderate 46.7% 
Screening 
completed by 
psychiatrist with 
client and carer  
Semi-structured 
clinical interview 
with client and 
carer by 
psychiatrist 
Mini PAS-ADD (for 
initial screening) 
 
 
Interview in line 
with full PAS-ADD 
interview 
ICD-10 
 
 
 
ICD-10 
Point-prevalence 
Schizophrenia 7.8% 
Delusional disorder - 
 
Schizophrenia 4.4% 
 (95% CI=0-8.4%) 
Delusional disorder 1.1% 
(95% CI=0-3.1%) 
Total psychotic disorder 
5.5%* 
6 
Holden & 
Gitlesen 
(2003) 
N=155 (165) 
Residents of local 
health authority’s 
accommodation 
facilities and those 
who live with 
parents and receive 
respite in Hedmark, 
Norway 
Age 18-46+ 
Gender: males 59% 
Mild 14%  
Moderate 27% 
Severe 35% 
Profound 23% 
Unknown 1% 
 
Forms mailed to 
staff member 
judged by local 
management to 
be in best position 
to rate participant 
PAS-ADD Checklist ICD-10 Point-prevalence 
Psychosis 15.5% 
4 
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Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic tool Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Holden & 
Gitlesen 
(2004) 
N=96 
Administrative 
sample receiving 
care from local 
health authorities in 
Hedmark, Norway 
Age ≥18  
(m = 46.4) 
Gender: males 55.2% 
Moderate 35.4% 
Severe 32.3% 
Profound 32.3% 
 
Telephone 
interview with 
informant staff 
member carried 
out by clinical 
psychologist 
Items 6-49 of Mini 
PAS-ADD Interview 
ICD-10 Psychosis 5.2% 4 
Taylor et 
al (2004) 
N=1155 
Hospital and 
community 
residents living 
within a country 
district, North East 
England 
Age 17-92 
(m=43.8, SD=15.2) 
Gender 57.5% male 
Level of ID not 
reported 
PAS-ADD Checklist 
completed by 
informants who 
had known 
participant for a 
median of 24 
months 
PAS-ADD Checklist ICD-10 Point-prevalence 
Psychotic disorders 
10.2% 
 
4 
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Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic 
tool 
Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Bailey 
(2007) 
N=121 
Random sample of 
adults using 
learning disability 
services in North 
Northamptonshire, 
England 
Age 20-77 (m=38.5, 
SD=13) 
Gender 62% male 
Moderate to 
Profound 
(distributions not 
reported)  
Clinical 
interview with 
client and/or 
carer by 
psychiatrist 
PPS-LD 
 
Clinical Point-prevalence 
Schizophrenia 0.8% 
Delusional disorder 0% 
Schizoaffective disorder 0% 
5 
DC-LD Schizophrenia/delusional episode 
0.8% 
 
ICD-10-DCR Schizophrenia 0.8% 
Persistent delusional disorder 0% 
 
DSM-IV Schizophrenia 0.8% 
Delusional disorder 0% 
Schizophreniform disorder 0% 
 
Cooper et 
al (2007b) 
N=1023 
Population-based 
sample of adults 
with ID in Greater 
Glasgow, UK 
between 2002 and 
2004  
Age 16-83 
(m=43.9) 
Gender 54.9% male 
Mild 38.9% 
Moderate 24.2% 
Severe 18.9% 
Profound 18.0% 
Clinical 
assessment 
with client and 
carer by 
psychiatrists 
PAS-ADD 
Checklist 
(initial 
screening) 
PPS-LD 
 
 
 
 
 
Point-prevalence 
All psychotic disorders including 
schizophrenia in remission: 
8 
Clinical 4.4% (95% CI= 3.2–5.8)  
DC-LD 3.8% (95% CI= 2.7–5.2)   
ICD-10-DCR 2.6% (95% CI= 1.8–3.8)  
     DSM-IV-TR 3.4% (2.4–4.7)  
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Study Population 
characteristics 
Participant 
demographics 
Assessment 
method 
Diagnostic tool Diagnostic 
criteria 
Rate of psychosis % 
 (95% CI) 
Quality 
rating (/8) 
Nettelbladt 
et al (2009) 
N=52 
Prospective cohort 
following 
geographically 
defined 
community sample 
between 1947 and 
1997, Sweden  
Age 42-82 
(median 61, range 42-
82) 
Gender 63% male 
Mild 58% 
Moderate 27% 
Severe/Profound 13% 
 Severity unspecified 
2% 
Retrospective 
application of 
DSM-IV criteria to 
information 
gathered during 
original 
psychiatrist 
examinations  
None (original 
examinations 
conducted prior to 
development of 
diagnostic 
assessments) 
DSM-IV Period prevalence 
Schizophrenia and other 
psychotic disorders 
7.7%* 
4 
Sheehan et 
al (2015) 
N=33,016 
Adults with ID 
drawn from The 
Health 
Improvement 
Network (THIN), a 
primary care 
database, UK. 
Age 18-≥80 (m=36.6, 
SD=16.4) 
Gender 58% male 
Level of ID unknown 
Electronic records 
for each person 
were examined 
Unknown Unknown Point-prevalence 
Schizophrenia 4% 
Other psychosis 2% 
Total psychosis 5.8%* 
4 
* Not reported in paper, but calculated for purpose of review 
Numbers in parentheses denotes total number in study; N denotes number included in prevalence calculation. 
Interviewer characteristics (i.e. psychiatrist/psychologist) were only recorded if this information was reported in the study. AIRP = Assessment and Information Rating Proﬁle; CGI = Clinical 
Global Impression; CPRS = Comprehensive Psychopathological Rating Scale; DC-LD = Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental 
18 
 
Retardation; DSM-III = Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, text revision; DSM-IV 
= Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; DSM-IV-TR = Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, text revision; ENCOR = Eastern Nebraska 
Community Office of Retardation; GAF = General Assessment of Functioning; ICD-10 -DCR= International Classification of Diseases, 10th edition, Diagnostic Criteria for Research; PAS-ADD 
Checklist = Psychiatric Assessment Schedule for use with Adults with Developmental Disabilities Checklist; PPS-LD = The Present Psychiatric State for Adults with Learning Disabilities; The 
MRC-HBC = The MRC Schedule of Handicaps, Behaviour, and Skills. 
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Nine studies consisted of samples of >100 participants (Göstason, 1985; Lund, 1985; Cooper, 1997; 
Salvador-Carulla et al. 1998; Holden & Gitlesen, 2003; Taylor et al. 2004; Bailey, 2007; Cooper et al. 
2007b; Sheehan et al. 2015), and three had samples of between 30 and 100.  Six studies used 
population-based sampling (Göstason, 1985; Lund, 1985; Cooper, 1997; Cooper, 2007b; Nettelbladt 
et al. 2009; Sheehan et al. 2015), five used administrative samples (Deb et al. 2001; Holden & 
Gitlesen, 2003, 2004; Taylor et al. 2004; Bailey, 2007), and one sampled adults working in a 
vocational centre (Salvador-Carulla et al. 1998).   Three studies failed to report the level and 
distribution of ID within their samples (Cooper, 1997; Taylor et al. 2004; Sheehan et al. 2015) and 
one reported the levels of ID, but not the distribution across the sample (Bailey, 2007).  However, 
these studies were included in the review as they identified their samples via learning disabilities 
services and registers.   Only two studies diagnosed psychosis according to DC-LD criteria; in addition 
to using clinical, DSM and ICD criteria (Bailey, 2007; Cooper et al. 2007b).  Five studies diagnosed 
according to ICD criteria (Cooper, 1997; Deb et al. 2001; Holden & Gitlesen, 2003, 2004; Taylor et al. 
2004), four used DSM criteria (Göstason, 1985; Lund, 1985; Salvador-Carulla et al. 1998; Nettelbladt 
et al. 2009) and one did not report which criteria was used (Sheehan et al. 2015).  Sheehan et al. 
(2015) reviewed existing electronic records, so it is likely that criteria will have varied according to 
the clinician and the year of assessment.  Half of the studies met the gold standard assessment of 
diagnosing via clinician interviews and standard diagnostic systems (Göstason, 1985; Cooper, 1997; 
Salvador-Carulla et al. 1998; Deb et al. 2001; Bailey, 2007; Cooper et al. 2007b). Three made 
diagnoses according to informant completion of general psychopathology screening tools (Holden & 
Gitlesen, 2003, 2004; Taylor et al. 2004); one diagnosed according to a computerised system (Lund, 
1985); one retrospectively applied DSM-IV criteria to information gathered during psychiatric 
examinations before diagnostic assessments were available (Nettelbladt et al. 2009); and one 
reviewed electronic records for existing diagnoses (Sheehan et al. 2015).   
 
5.2 Prevalence of psychosis 
Of the 12 studies, only one investigated the prevalence of psychosis as a primary outcome, albeit as 
part of a wider study into the prevalence of mental illness (Cooper et al. 2007b).  The rates from all 
12 studies were combined in order to calculate a mean prevalence of psychosis, which was found to 
be 7.1% (95% CI = 3.9-10.3) with a range of 0.8 to 17.7%.  However, given the variation in study 
quality, this rate is likely to be subject to bias.  In order to reduce the impact of bias, the average 
prevalence was calculated again using only the five studies rated as high quality (Göstason, 1985; 
Lund, 1985; Cooper, 1997; Deb et al. 2001; Cooper et al. 2007b).  This resulted in a lower prevalence 
of psychosis, at a rate of 4.5% (95% CI = 2.5-6.5) with a range of 2.9 to 6.6%.  A correlation (Pearson’s 
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r as data were found to be parametric) revealed no significant association between study quality and 
prevalence rate (r= -0.421., p=0.18). 
 
6. Discussion 
The prevalence of psychosis in adults with ID was found to occur at a rate of 7.1% (95% CI = 3.9-
10.3), which is higher than previously suggested rates ranging between 0.8% and 5% (Smiley, 2005).  
This rate is based on a wide range of scores (0.8-17.7%) reported by studies varying in methodology 
and consequently, quality.  High quality studies reported a lower range of prevalence (between 2.9% 
and 6.6%) which is more in keeping with previous estimates.  This suggests that the rates reported at 
the extremes of the range are the result of greater methodological limitations.  These limitations 
include sample size and composition, method of assessing psychosis, type of diagnostic criteria and 
type of psychosis that was reported.   
For example, the highest prevalence rate of 17.7% was found in a vocational sample, the 
majority of whom were referred from psychiatric institutions (Salvador-Carulla et al. 1998).  Hence 
mental illness was likely to be more prevalent, and the authors suggested it was not representative 
of other occupational centres in Spain.  Second, 90% of the sample comprised people with mild and 
moderate ID, with only 3.1% having severe and profound ID (6.9% were ‘unspecified’).  Given the 
difficulties of diagnosing psychosis in people with more severe ID (Smiley, 2005), it is to be expected 
that predominantly mild/moderate samples would report higher rates of psychosis than those with a 
higher proportion of less able people.  For example, the lowest prevalence rate of 0.8% was reported 
by Bailey (2007) who recruited a comparable sample to Salvador-Carulla et al. (1998) in terms of size 
(N=121 vs. 120), age (m=38.5vs. 36.1), gender (male 62% vs. 70.8%), assessment (both psychiatric 
interview) and diagnostic criteria (DSM-IV vs. DSM-III-R), respectively.   The main difference between 
the samples was the level of ID, with Bailey’s (2007) sample consisting exclusively of people with 
moderate to profound ID (distribution not reported).  Therefore, it is likely that the different rates 
found between the two samples can in part be attributed to the included levels of ID.  Third, the 
rates reported could be impacted by cultural differences, with Salvador-Carulla et al. (1998) 
investigating a Spanish sample; however, no other Spanish samples were included so it is not 
possible to determine whether a true cultural difference exists.  Fourth, it is possible that the high 
proportion of males (70.8%) in this sample contributed to the higher rate of psychosis.  Although 
Bailey’s (2007) sample also consisted of a high proportion of males (62%), this would be somewhat 
inconsequential if the majority had more severe ID and communication impairment (meaning that 
psychosis could not be accurately diagnosed).  Taylor et al. (2004) and Cooper et al. (2007b) were 
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the only studies to investigate the possible relationship between psychosis prevalence and gender, 
with both reporting no significant associations.  However, a general population review has shown 
incidence and relapse of psychotic illness to be lower in females than males (Ochoa et al. 2012); but 
no real conclusions can be made without further investigation within ID populations.  
High rates of psychosis were also reported by Holden & Gitlesen (2003) and Taylor et al. 
(2004), i.e. 15.5% and 10.2% respectively.  Both studies used informant completion of the Psychiatric 
Assessment Schedule for use with Adults with Developmental Disabilities (PAS-ADD) Checklist.  It is 
likely that use of the PAS-ADD Checklist and the lack of clinical interview contributed to the higher 
rates.  For example, Holden and Gitlesen (2003) dichotomised symptoms as present or absent, 
rather than using the original 4-point scale designed for the PAS-ADD Checklist.  Using a 
dichotomous scale could lead to higher scores, given that symptoms which were present but had 
‘not been a problem’ would be scored as ‘1’ rather than ‘0’.  However, the authors did not report 
amending the cut-off threshold for psychotic disorders in order to counterbalance this change.  
Hence, it is unsurprising that a high proportion of the sample scored above the threshold of ‘2’ for a 
psychotic disorder.  Although Taylor et al. (2004) used the original 4-point scale, their high psychosis 
rate may be attributable to their sample consisting of both hospital and community residents. 
The lower range of prevalence rates are also likely to be influenced by methodological 
differences.  As previously stated, the lowest rate of 0.8% reported by Bailey (2007) may be due to 
the sample consisting exclusively of adults with moderate to profound ID.  Given the subjective 
nature of psychosis, diagnoses tend to rely upon self-reports.  Consequently, it is not currently 
possible to diagnose psychosis in those with more profound difficulties who cannot communicate 
(Cooper et al, 2007b).  Hence, it would be expected that lower rates of psychosis would be reported 
in samples consisting of less able people.  Low rates of 2.9% and 3% were also reported by Cooper 
(1997) and Göstason (1985), respectively.  Göstason’s (1985) sample consisted of adults with mild 
and severe ID (57% vs. 43%, respectively) and it is likely that this distribution contributed to the 
lower rate.  Göstason (1985) reported that schizophrenic disorders could not be demonstrated with 
any degree of certainty in those with severe ID.  However, the whole sample was used as the 
denominator to calculate the overall rate of 3%.  Hence, this is likely to be an underestimate of the 
true prevalence of psychosis.  Cooper (1997) did not report the level or distribution of ID included in 
their sample, so it is not possible to conclude whether the low prevalence rate reported may also be 
explained in this way.   
This calculation limitation is not restricted to the studies reporting lower prevalence rates of 
psychosis.  Cooper et al. (2007b) highlighted that they used the entire ID population as the 
denominator for calculating the prevalence rate, despite not being able to diagnose psychosis in 
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those with more severe impairments.   Hence, they reported that their rates were likely to be an 
undercount of the true prevalence of psychosis.  A further seven of the 10 studies that reported 
level of ID included people with profound disabilities.  Their calculations were based on the total 
population and so are also likely to have underestimated the rate of psychosis (Lund, 1985; Salvador-
Carulla et al. 1998; Holden & Gitlesen, 2003, 2004; Bailey, 2007; Nettelbladt et al. 2009).  Thus, the 
higher the proportion of severe and profound ID in a sample, the greater the underestimate is likely 
to be.      
Another possible cause of underestimating prevalence of psychosis is the type of diagnostic 
criteria used.  Despite known limitations of using general population criteria in people with ID 
(Cooper et al. 2007a), only two of the seven studies carried out after publication of the DC-LD used 
this ID specific criteria (Bailey, 2007; Cooper et al. 2007b).  Given that 10 studies included in this 
review used general population criteria, it is likely that the calculated rate of 7.1% is actually an 
underestimate of the true prevalence of psychosis in the ID population. 
However, it is also likely that the seven studies including adults with mild ID in their samples 
(Göstason et al. 1985; Lund, 1985; Salvador-Carulla et al. 1998; Deb et al. 2001; Holden & Gitlesen, 
2003; Cooper et al. 2007; Netteldbladt et al. 2009) will have over-estimated the prevalence of 
psychosis in the wider ID population.  Despite four of these studies recruiting population-based 
samples (Göstason et al. 1985; Lund, 1985; Cooper et al. 2007; Netteldbladt et al. 2009), it is unlikely 
that they were able to fully identify all adults with mild ID within their specified geographical area.  
Whilst good ascertainment rates of people with moderate to profound ID can be achieved via case 
registers, learning disabilities services, or specific social funding etc., these methods are less 
successful at identifying those with mild ID (Smiley, 2005).  In fact, many adults with mild ID are not 
known to learning disabilities services, unless they have additional needs requiring support (such as 
psychiatric illness).  Therefore, those adults with mild ID identified via case registers and learning 
disabilities services etc. are likely to have more needs and hence result in a biased sample.  Thus, 
those studies including adults with mild ID may have over-estimated the prevalence of psychosis 
within the ID population.               
 
Of the 12 studies included, only one received the highest possible quality rating score 
(Cooper et al. 2007b).  The authors investigated a large population-based sample, and employed 
psychiatric interviews according to clinical, ID and general population criteria.  As noted by the 
authors, the rate of 4.4% may be an underestimate due to the method of calculation.  The authors 
also used the PAS-ADD Checklist to screen for participants requiring psychiatric interview.  The PAS-
ADD Checklist, although designed for the ID population, is derived from general population criteria.  
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When used in a sample of adults with mild to severe ID, it failed to recognise 25% of those with a 
clinical diagnosis of schizophrenia (Moss et al. 1996).  Hence, it may not be the most appropriate 
screening tool for a study investigating the prevalence of psychosis.  However, Cooper et al. (2007b) 
addressed this issue by adding items relating to psychosis to the checklist, and lowering the 
threshold for psychotic disorders.  Interestingly, of the psychopathology tools used by 10 of the 
studies as part of their assessment (Göstason, 1985; Cooper, 1997; Salvador-Carulla et al. 1998; 
Cooper et al. 2007b) or for diagnostic purposes (Lund, 1985; Deb et al. 2001; Holden & Gitlesen, 
2003, 2004; Taylor et al. 2004; Bailey, 2007), none were designed specifically to detect psychosis in 
the ID population.              
 
6.1 Limitations 
Strict adherence to the predetermined criteria prevented the inclusion of some studies reporting 
rates of psychosis in ID populations.  For example, Morgan et al. (2008) investigated schizophrenia in 
13, 295 adults identified through cross-linkage of the Western Australian population-based 
psychiatric register and the intellectual disability register from 1983 onwards.  They reported rates 
of schizophrenia to be 3.6% and lifetime prevalence of psychosis to be 8.4%.  However, adults with 
borderline intellectual functioning were included in this study, and it was not possible to calculate 
the prevalence rate of only those with mild to profound ID.  Similarly, the investigation of mental 
illness carried out by White et al. (2005) could not be included because their sample consisted of 15-
64 year olds; it was not possible to calculate the prevalence rate of those aged ≥16 years old.  The 
authors used the Australian national ‘Disability, Ageing and Carers Survey, 1998’ to carry out 
secondary analysis of data collected on 42, 664 people.  They reported prevalence of psychotic 
disorders to be 1.3%, which is lower than the majority of rates reported in this review.  Finally, 
literature search and selection, and quality appraisal was conducted by the first author (AM) only; 
reliability could have been enhanced through an additional independent scorer.   
 
6.2 Future research  
Although numerous factors were identified as contributing to both the over- and under-estimation 
of prevalence, it is likely that the true rate of psychosis in the ID population is higher than previously 
estimated.  Despite five of the studies being rated as high quality, future research into the 
prevalence of psychosis is still needed.  Only one study investigated psychosis as a primary outcome, 
and this was as part of a wider study into the prevalence of mental ill-health (Cooper et al. 2007b).  
Given that it is currently not possible to diagnose psychosis in people who cannot communicate, 
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future research should exclude such individuals from their calculations of prevalence.   They should 
also be clear about the levels and distribution of ID in their samples; use clinical or DC-LD criteria and 
if an initial screening phase is used, a tool should be developed specifically for screening psychosis in 
the ID population.    
Future research should also seek to determine why adults with ID are more vulnerable to 
psychosis than the general population.  Of the studies included in this review, only five investigated 
factors associated with psychosis (Cooper, 2007b; Holden & Gitlesen, 2003, 2004; Taylor et al. 2004; 
Cooper et al. 2007b), but with the exception of the Cooper et al. (2007b) study, these tended to be 
restricted to the relationship between psychosis and basic demographics.  Finally, efforts must be 
made to accurately identify those with psychosis so that they can receive appropriate support and 
treatment.  To this end, a psychosis screening tool designed specifically for the ID population would 
be of clinical value.  
7. Conclusions 
The prevalence of psychosis in adults with ID was found to be 7.1%, and limitations in the literature 
leading to both under- and over- estimates of psychosis have been highlighted. There is a paucity of 
research with the primary aim of identifying the prevalence of psychosis in the ID population, which 
may partially explain the moderate quality of over half of the studies.  Hence, there is a need for 
future research to investigate the rate of psychosis within the ID population, preferably through the 
use of psychosis screening tools and diagnostic criteria designed specifically for this population.  
Policy makers and Healthcare providers should consider that there are likely to be more people with 
ID affected by psychotic disorders than previously thought; consideration needs to be given to how 
best to accurately identify such individuals and ensure they receive access to appropriate treatment.      
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Plain English Summary 
Title 
Glasgow Psychosis Screening Tool for use in Adults with Intellectual Disabilities 
(GPS-ID): Development and psychometric properties 
 
Background 
Psychosis occurs at a higher rate in people with intellectual disabilities (ID) 
than in the general population.  Despite this, there are no psychosis screening 
measures that have been developed specifically for people with ID.  Some 
psychosis screening tools developed for the general population have been 
used with people with ID.  However, there is evidence to suggest that these 
general population measures may not be the best tools to detect psychosis in 
people with ID. 
 
Aims  
To develop a psychosis screening tool that can be used with people with mild 
and moderate ID. 
 
Methods 
Participants 
Two groups of participants were recruited: a focus group and a testing group. 
Inclusion criteria 
Focus groups 
 Adults aged 16 or older with an ID who have psychosis 
 Family or paid carers of adults with an ID who have psychosis 
Testing group 
31 
 
 Adults aged 16 or older with an ID who have a diagnosis of 
psychosis 
 Adults aged 16 or older with an ID, who do not have psychosis 
Exclusion criteria 
 Adults with autism 
 Adults with dementia 
 Adults with severe and profound levels of ID 
 
Recruitment 
Information about the study was given to community and inpatient mental 
health services.  People who met the study criteria were told about the study 
by a clinician they knew (such as their nurse).  If they were interested in finding 
out more, they were given information sheets, allowing them to indicate their 
interest in the study.   
 
Consent 
A trainee clinical psychologist spoke to everyone interested in the study and 
answered their questions.  Those who wanted to take part were asked for their 
consent, and/or the consent of their welfare guardian.  
 
Design of study and data collection 
The focus group helped inform the new scale by discussing their experiences of 
psychosis.  The testing group were interviewed with both the final scale, and 
an existing psychosis scale developed for the general population (Hatton et al. 
2005).  They were also given the opportunity to provide any feedback they had 
on the new tool. 
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Main findings and Conclusions 
A new psychosis screening tool was developed for adults with ID.  It was able 
to distinguish between ID adults with psychosis, and those without psychosis.  
Further investigation is needed to test how well the tool works.   
 
Practical applications and Dissemination 
The tool can be used to help identify people with ID who might have psychosis, 
and need further assessment. 
The study will be submitted for publication in a scientific journal.    
 
References 
Hatton, C., Haddock, G., Taylor, J. L., Coldwell, J., Crossley, R., & Peckham, N. 
(2005). The reliability and validity of general psychotic rating scales with 
people with mild and moderate intellectual disabilities: an empirical 
investigation. Journal of Intellectual Disability Research, 49(7), 490-500. doi: 
10.1111/j.1365-2788.2005.00696.x 
 
33 
 
1. Abstract  
Background  
Prevalence of psychosis is known to be higher in adults with intellectual disabilities (ID) than in the 
general adult population.  However, there have been no attempts to develop a psychosis screening 
tool specifically for the adult ID population.  The present study describes the development and 
preliminary evaluation of a new measure, the Glasgow Psychosis Screening tool for use in Adults 
with Intellectual Disabilities (GPS-ID). 
Method 
An item pool was generated following: 1) focus groups with adults with ID and psychosis, and their 
carers and/or workers; 2) expert input from clinicians.  A draft scale was compiled and refined 
following expert feedback.  The new scale, along with the Psychotic Symptom Rating Scales was 
administered to 20 adults with ID (10 with and 10 without psychosis) and their relative or carers.      
Results 
The GPS-ID total score, self-report subscale and informant rating-subscale differentiated psychosis 
and non-psychosis groups.  The tool had good internal consistency (Cronbach’s α=0.91), and a cut-
off score ≥4 yielded high sensitivity (90%) and specificity (100%).  The method of tool development 
supports face and content validity.  Criterion validity was not supported.      
Conclusions      
Preliminary investigation of the tool’s psychometric properties is positive, although further 
investigation is required.  The tool is accessible to adults with mild to moderate ID and can be 
completed in 15-30 minutes.  The GPS-ID is not a diagnostic tool, therefore any adult exceeding the 
cut-off score of ≥4 should receive further assessment.  
2. Background 
The point prevalence of psychosis in adults with ID has been estimated to range between 0.8% and 
5.0% (Bailey, 2007; Lund, 1985, respectively).  Prevalence of psychosis in the general adult 
population has been estimated at a lower rate, ranging between 0.4% and 1.2% (Jenkins et al. 1997; 
Brugha et al. 2005; Wittchen et al. 2011); suggesting psychosis is twice as prevalent in the adult ID 
population.  Psychopathology tools are regularly used in clinical practice to both screen for, and 
monitor symptomatology.  However, despite the higher prevalence of psychosis in adults with ID, 
there is currently no psychosis screening tool developed for this population.           
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Some general psychopathology screening tools developed for the ID population contain 
items or subscales that screen for psychosis, such as the Psychiatric Assessment Schedule for use in 
Adults with Developmental Disabilities Checklist (PAS-ADD Checklist; Moss et al. 1998).  However, 
there are limitations associated with using these screening tools to detect psychosis.  They are 
derived from general population criteria (i.e. the ICD or DSM), and can lead to under-recognition of 
some psychiatric disorders when used in adults with ID.  For example, in a sample of 1023 adults 
with mild to profound ID, psychosis was found to vary between 2.6% and 4.4% according to type of 
diagnostic criteria (Cooper et al. 2007).  Rates were lowest for general population criteria ICD-10-
DCR (the International Classification of Diseases, 10th edition, Diagnostic Criteria for Research) and 
DMS-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, text revision) and 
highest according to ID criteria, the DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with 
Adults with Learning Disabilities/Mental Retardation and clinical diagnosis) and clinical diagnosis.  It 
is likely that the latter criteria would allow a more accurate rate of psychosis to be determined, given 
that the DC-LD was developed specifically for the ID population (Royal College of Psychiatry, 2001), 
and clinical criteria has more flexibility to accommodate the pathoplastic effects of ID.   
The limitations of using general diagnostic criteria are evident in research investigating the validity of 
the PAS-ADD Checklist to detect schizophrenia (Moss et al. 1996a).  The PAS-ADD Checklist is an 
informant-rating measure, designed to screen for psychopathology in adults with ID.  It uses 29 
items to screen experiences occurring within the past four weeks, and employs the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN) algorithm (WHO, 1994), which assigns diagnoses 
according to strict application of ICD-10 research criteria.  Ninety-eight participants with mild to 
severe ID and a range of psychiatric diagnoses were screened by trained interviewers using the PAS-
ADD Checklist.  Interviewers were blind to participant’s diagnosis, as determined by their 
psychiatrist.  The PAS-ADD Checklist failed to recognise 25% of those participants determined by 
their psychiatrists as having active symptoms of schizophrenia.  Auditory hallucinations were the 
only first rank symptom that could be detected with any frequency.  Despite delusions being noted 
frequently, participants and informants could not provide a ‘sufficiently unequivocal’ account to 
fulfil the SCAN algorithm, and hence did not meet the PAS-ADD Checklist threshold for an ICD-10 
diagnosis.  This has been an area of contention, with some suggesting that people with ID may 
present with an atypical profile of psychosis; therefore, the use of standard psychiatric diagnostic 
criteria may fail to recognise people with mild ID and distressing psychotic symptoms (Hatton et al. 
2005).  
Researchers have addressed some of the aforementioned issues by developing screening 
tools for specific psychiatric disorders in the ID population.  For example, the Glasgow Depression 
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Scale for people with a Learning Disability (GDS-LD; Cuthill et al. 2003) and the Glasgow Anxiety Scale 
for people with an Intellectual Disability (GAS-ID; Mindham & Espie, 2003) considered 
symptomatology included in both the ICD-10 and the DC-LD.  Both studies employed focus groups of 
adults with ID to inform item selection, and developed screening tools with good psychometric 
properties (Appendix 3.1).  The tools screen symptoms occurring within the past week, and both are 
designed to be administered to individuals with ID.  Neither is intended as a diagnostic tool; 
however, both purport to be useful for clinical and research practice, allowing screening and 
monitoring of symptoms (Mindham & Espie, 2003; Cuthill et al. 2003).  As of yet, no similar attempt 
has been made to develop a screening tool for psychosis.  Given the high prevalence of psychosis in 
the ID population, and the limitations associated with existing measures, there is a need for a tool 
that is sensitive to the manifestation of psychosis in this population, and accessible to these 
individuals and their families or carers.  Such a tool would be useful to both detect illness and 
monitor treatment related changes.  
More recently, researchers have investigated the utility of using psychosis screening tools  
developed for the general population, such as the PSYRATS (Haddock et al. 1999) and the Positive 
and Negative Syndrome Scales (PANSS; Kay et al. 1989) with the ID population (Hatton et al. 2005).  
The PSYRATS consists of an auditory hallucinations and delusions subscale, and the PANSS consists of 
positive symptoms, negative symptoms and general symptoms subscales.  The PSYRATS requires 
respondents to make complex ratings about their experiences, whereas the PANSS requires 
respondents to describe their symptoms in sufficient detail to allow the interviewer to rate them 
accordingly.     
Hatton et al. (2005) used the PSYRATS and the PANSS to interview 62 adults with mild ID.  
The participants were identified as having psychosis by either psychiatrist clinical judgement 
according to ICD-10 criteria, or PAS-ADD Checklist screening.  A range of adequate psychometric 
properties were reported for both tools (Appendix 3.2).  However, the authors suggested that 
further investigation was necessary, particularly regarding applicability of items concerning negative 
symptoms and delusions.  It should be considered that the authors used general population 
diagnostic criteria to both select their sample and diagnose psychosis.  Therefore, it is possible that 
individuals presenting with an atypical profile would not have been identified as having psychosis, 
and hence would have been ineligible for the study.  
 In addition to these issues, tools developed for the general adult population do not take 
into account the language and comprehension needs of people with ID.  For example, the PSYRATS 
depends upon self-report judgements of complex constructs (e.g. frequency, duration, intensity etc.) 
regarding abstract concepts.  Questions about time or requiring a judgment of frequency or degree 
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have been found to be problematic for many people with ID, as have questions about abstract 
concepts.  If the answer is not known, the question is too long or the structure is too complex, 
people with ID are more likely to acquiesce (Finlay and Lyons, 2001).  Hence, despite the PSYRATS 
having adequate psychometric properties, it may not be the most accessible screening tool for 
adults with ID.   
Finally, some researchers have suggested that self-report of psychotic symptoms (rather 
than informant-report) can be crucial for detecting psychosis in people with ID (Moss et al. 1996b).  
In the interest of both increasing sensitivity and equality, adults with ID should have the opportunity 
to self-report their symptoms, and amendments should be made to support this wherever possible.  
Given that adults with ID are more vulnerable to psychotic illness than the general population, and 
self-report may be fundamental to detecting psychosis, it seems imperative that there is an 
appropriate psychosis screening tool which is accessible to the adult ID population.    
 
3. Aims  
To develop and evaluate a psychosis screening tool that is appropriate for use in the mild to 
moderate adult ID population. 
4. Method 
4.1 Ethical approval 
A research proposal was developed (see Appendix 4) and ethical approval was sought and obtained 
from Scotland A REC, NHS Greater Glasgow & Clyde R&D and NHS Ayrshire & Arran R&D (see 
Appendices 6.1-6.3.  Following a substantial (Appendix 6.4) and non-substantial (Appendix 6.7) 
amendment to the original study design, further approval was sought and obtained (see Appendices 
6.5-6.9).     
  
4.2 Study strategy 
First, the literature was reviewed in order to inform the research methodology, and to develop a 
suitable interview schedule for focus groups.  Next, focus groups were consulted in order to inform 
appropriate item selection for the screening tool.  Experts in the field were also consulted in order to 
further supplement item selection.  A draft tool was then developed and reviewed by an expert 
panel.  It was refined according to expert feedback, and used to interview adults with ID, with and 
without psychosis.  Finally, the psychometric properties of the screening tool were tested.   
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4.3 Review of literature  
First, in view of both the importance of self-reports in detecting psychosis (Moss et al. 1996b), and 
the limitations associated with relying upon self-reports regarding complex concepts in this 
population (Finlay and Lyons, 2001), it was decided that information would be sought from several 
sources: individuals with ID and psychosis, their carers/workers and experts in the field.  This is in 
line with recommendations for scale development by Steiner et al. (2015), who highlight that while 
“clinicians may be the best observers of the outward manifestation of a trait or disorder, only those 
who have it can report on the more subjective elements” (pp. 20).  Second, given the limitations 
associated with using general population criteria, it was deemed prudent to base the item pool on ID 
criteria, the DC-LD for ‘Schizophrenic/delusional episode’ (Royal College of Psychiatrists, 2001; 
Appendix 5.1).  An interview schedule was subsequently developed, whereby each DC-LD criterion 
was paired with prompt questions to elicit those specific experiences (see Appendix 7.1).      
 
4.4 Recruitment procedure 
Health and Social Care workers within NHS Greater Glasgow & Clyde were provided with information 
sheets, and asked to invite people meeting the following criteria to participate in the study: 
Inclusion criteria 
Focus groups 
 Adults aged ≥16 with a mild to moderate ID who have reasonable verbal 
communication i.e. are able to express themselves, and a diagnosis of psychosis. 
 Relatives or workers of adults with mild to moderate ID who have a diagnosis of 
psychosis and wish to take part in the focus group. 
Field test groups 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication and a diagnosis of psychosis, with active symptoms. 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, and do not have a diagnosis of psychosis. 
Exclusion criteria 
 Adults with a diagnosis of autism. 
 Adults with a diagnosis of dementia. 
 Adults with severe and profound ID. 
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First, potential participants were identified by members of their health care team between March-
June 2016.  They were given information sheets containing reply slips to indicate their interest in 
participating.  Consent was sought in accordance with the Adults with Incapacity (Scotland) Act): it 
was given by those who had capacity to consent to take part in research, and by the nearest relative 
or welfare guardian/attorney for those who wanted to participate but did not have capacity to 
consent.  Next, individuals and their relative or worker participated in the focus groups.  Following 
development of the new tool, participants and their relative or worker were interviewed using the 
GPS-ID and the PSYRATS.  Finally, Health and Social Care workers were contacted and asked to 
provide participant’s age, gender, level of ID and diagnosis.   
 
4.5 Focus groups and expert input 
It was intended that two focus groups would be recruited, totalling six to 10 people with ID and their 
relative or worker.  Similar numbers were found to be appropriate in the development of previous ID 
screening tools (Mindham & Espie, 2003; Cuthill et al. 2003).  The aim was to elicit the language 
people with ID and their relative or worker use to describe experiences of psychosis.  The first focus 
group lasted approximately 60 minutes and consisted of two adults with ID and their support 
workers.  The second focus group lasted approximately 85 minutes and consisted of one adult with 
ID, her mother and her Community Learning Disability Nurse.   All three participants were female 
aged 50-56 (mean 54 years); one had a borderline level of ID, and two had a mild ID.  All three had a 
diagnosis of schizophrenia, two of which had active symptoms.  Both groups were audiotape-
recorded and then transcribed.  No one used the word ‘psychosis’, nor did they report any word to 
encompass their experiences.  Instead, those with ID talked about their specific experiences, for 
example “Och, they [the voices] were calling me Cows an that, whore, uh, umpteen things”; while 
their relative or worker talked about the behaviours they would notice, for example “we would 
maybe see [client] withdraw. She likes to stay in her room regardless but, you could physically see her 
withdrawing into herself or she would think we were talking about her or you know different things 
like that and complain to outside agencies that we were drugging her or whatever, things like that” 
(see Appendix 7.2 for further excerpts).   
Next, expert input was sought from three adult inpatient Learning Disability Nurses who 
reported their observations of adults with ID experiencing psychosis.  They talked about behavioural 
observations (e.g. patients gaze shifting as if in response to something unseen), and gave examples 
of things patients might say when experiencing psychosis (e.g. “I’m a spy”).  This discussion lasted for 
two hours and the content was recorded by hand (Appendix 7.3). 
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4.6 Drafting the tool and expert feedback 
Given that focus group members did not use specific words to describe their experiences, but could 
nonetheless report their experiences; it was decided that an accessible screening tool would 
facilitate people to describe their own experiences of psychosis.  A draft tool with clinician 
instructions for administration was compiled, comprising two sections screening experiences and 
behaviours.  The first section consisted of three self-report questions regarding auditory 
hallucinations, visual hallucinations and delusional beliefs.  Each question included several prompts 
and examples.  The examples were constructed from the focus groups and expert input.  It was 
hoped that these examples would 1) facilitate participants’ understanding of the complex concepts 
being discussed; and 2) help normalise psychosis and hence encourage participants to describe their 
own experiences.  Participants were then asked to rate whether their experience had made them 
feel ‘ok/a little upset’ (1) or ‘very upset’ (2).  If no evidence of a psychotic experience was described, 
experiences were rated as ‘no’ (0).  Readability of each self-report question was assessed using the 
‘Flesch-Kincaid readability tests’ tool (Table 1) within Microsoft Word.  A higher Flesch Reading Ease 
score (ranging 0-100) and a lower Flesch-Kincaid Grade level score indicates easier reading material. 
 
Table 1 Readability of self-report questions 
Self-report Question Flesch Reading Ease Flesch-Kincaid Grade level 
A1 89.8 3.3 
A2 85.6 4.2 
A3 81.8 4.5 
      
The second section was designed to be completed by an informant who knew the person 
well.  It consisted of items regarding behavioural observations (taken from the focus groups and 
expert input).  In keeping with GAS-ID and GDS-LD response formats, informants were asked to rate 
whether behaviours had occurred ‘no/never’ (0), ‘sometimes’ (1) or ‘always/a lot’ (2).       
Next, the draft tool was reviewed by an expert panel, consisting of two Psychiatrists, one 
Psychologist and one Speech and Language Therapist, all specialising in adults with ID.  It was 
decided that a negative symptoms self-report question would not be included, given that focus 
group participants with ID did not describe such symptoms; both psychiatrists supported this 
decision.  Feedback was provided regarding the time period over which symptoms are screened; the 
format, content and language of questions; the response format; and the instructions for 
administration (see Appendix 7.4).  The tool was subsequently refined according to feedback.  For 
example, the time scale was increased from two weeks to four weeks; the instructions 
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recommended establishing an ‘anchor’ event for this time period; general questions asking how the 
individual had been feeling were included in the first section, before more specific prompts were 
added; and a visual aid was provided to help individuals rate their level of distress.  Similarly, more 
general questions about the individual’s wellbeing were added to the second section, one item was 
removed from the list of questions and three additional questions were included.  The resulting 
screening tool consisted of three self-report items and 20 informant-report items concerning 
symptoms during the past four weeks.  Thus, the GPS-ID (Appendix 8) yields a total score for the 
screening tool (0-46), as well as subtotals for the self-report scale (0-6) and the informant scale (0-
40).  The self-report scale is further divided into a hallucinations subscale (0-4) and a delusions 
subscale (0-2).                
 
4.7 Materials 
Participants were interviewed with the GPS-ID and the PSYRATS (Appendices 8 and 9).  The PSYRATS 
consists of an auditory hallucinations scale (11 items) and a delusional beliefs scale (6 items).  All 
items relate to experiences occurring within the past week and are rated according to a five-point 
scale ranging from 0-4. 
 
4.8 Analysis 
First, descriptive statistics were used to investigate the spread of the data. Next, the following 
psychometric properties of the GPS-ID were investigated: 
 Content validity “is the degree to which elements of an assessment instrument are relevant 
to and representative of the targeted construct for a particular assessment purpose” 
(Haynes et al. 1995, pp. 238).  It is determined via expert judgement.   
 Criterion validity refers to the extent to which the GPS-ID scores correlate with the PSYRATS 
scores for the psychosis group.  A correlation coefficient of ±.3 represents a medium effect 
and ±.5 represents a large effect (Field, 2013).   
 Discriminant validity refers to the ability of the GPS-ID to discriminate between the psychosis 
and non-psychosis groups.  A Mann-Whitney test was used to investigate the discriminant 
validity of the GPS-ID total scores, self-report subscale and informant-rating subscale. 
 Internal consistency refers to how well the items on the GPS-ID measure the construct of 
psychosis.  It was tested using Cronbach’s α.  An alpha of >.9 indicates ‘excellent’ internal 
consistency, and an alpha of 0.8-.09 indicates ‘good‘ internal consistency (George & Mallery, 
2003).   
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 Sensitivity refers to the ability of the GPS-ID to correctly identify the psychosis group as 
having psychosis; and specificity refers to the ability of the GPS-ID to correctly identify the 
non-psychosis group as not having psychosis.  Sensitivity and specificity were investigated 
using Receiver Operator Characteristic (ROC) curve analysis.  Values closer to 100% 
represent greater sensitivity and specificity.         
 
4.9 Sample size and power calculation 
A sample size of 12 participants per group are recommended for a pilot study (Julious, 2005).  The 
statistical software ‘G*Power 3.0.10’ was used to perform a sensitivity analysis for testing between 
group differences on the GPS-ID.  The parameters: α err prob (0.05), power 1-β err prob (0.8), 
sample size group 1 (12), sample size group 2 (12) produced an effect size of 1.0, indicating that 
recruiting 12 participants per group would have an 80% chance of detecting a large effect.  
5. Results 
5.1 Participants 
The psychosis and non-psychosis group each consisted of 10 participants.  Two psychosis group 
participants were described as having mild-moderate ID.  Due to the small numbers per group, they 
were re-classified as ‘moderate’ in order to allow Chi Squared analysis to be conducted.  
Demographics of each group are described in Table 2, which shows there were no significant 
differences in terms of age, gender and level of ID.  
 
Table 2 Comparisons of characteristic between psychosis and non-psychosis group 
Characteristics Psychosis group  
(n=10) 
Non-psychosis group 
(n=10) 
Test 
statistic 
P 
Age: mean (SD)  38.5 (12.7) 39.8 (12.9) t=.227 .823 
Gender: n (%) 
              Male 
              Female 
 
6 (60%) 
4 (40%) 
 
4 (40%) 
6 (60%) 
 
ᵡ2=.800 
 
.656 
Level of ID: n (%) 
Borderline 
Mild 
Moderate  
 
1 (50%) 
5 (50%) 
4 (50%) 
 
1 (50%) 
5 (50%) 
4 (50%) 
 
ᵡ2=.000 
 
1.000 
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Mental health diagnoses within the two groups are displayed in Table 3.  The total number of 
diagnoses exceed the total sample size due to some participants having multiple diagnoses. 
 
Table 3 Mental health diagnoses within psychosis and non-psychosis group  
Psychiatric diagnosis Psychosis Group (n=10) 
Psychosis 4  
Schizophrenia 2 
Schizophrenia affective disorder 3  
Delusional disorder 1  
Depression 1  
  
 Non-psychosis Group (n=10) 
Complex trauma 2  
Depression 2  
None 7  
 
5.2 Distribution of GPS-ID and PSYRATS scores 
Total GPS-ID scores ranged from 0-27, with a median of 2 and an interquartile range of 13.75.  Total 
PSYRATS scores ranged from 0-41, with a median of 0 and an interquartile range of 0.  Plotted data 
indicated a non-normal distribution, which was confirmed by Kolmogorov-Smirnov’s test of 
normality. Total GPS-ID scores D(20) =.293, p=.004, and total PSYRATS scores D(19) =.468, p=.000 
significantly deviated from a normal distribution.  Hence, non-parametric analyses were used for all 
inferential statistics.  
 
5.3 Validity 
Content Validity   
The method used to create the GPS-ID supports the face and content validity of the screening tool.  
Twelve of the 23 items received a score of ‘0’ for over half of the psychosis group participants, 
suggesting that item content did not describe their experiences of psychosis.  However, all items 
received a score of ‘1’ or ‘2’ for at least one psychosis group participant; suggesting that the GPS-ID 
screens for a wide range of behaviours indicative of psychotic experience.   
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Criterion validity 
To investigate criterion validity, total GPS-ID scores were correlated with total PSYRATS scores for 
nine psychosis group participants (PSYRATS scores were incomplete for one participant).  The data 
were analysed using Spearman’s correlation coefficient (which excludes missing cases), yielding 
rho=.456, p=.217.  Although non-significant, the rho of .456 indicates that there may be a small to 
moderate relationship between GPS-ID and PSYRATS total scores.    
 
Discriminant validity 
Figure 1 illustrates the ability of the GPS-ID to discriminate between the psychosis and non-psychosis 
groups.  Mann-Whitney tests revealed that GPS-ID total scores, self-report subscale scores and 
informant-report subscale scores were all significantly higher in the psychosis group than the non-
psychosis group (Table 4).     
  
Table 4 Differences between psychosis and non-psychosis GPS-ID scores  
GPS-ID scores Mdn (IQR) U z p 
value 
Effect 
size (r) Psychosis Non-psychosis 
GPS-ID total scores 13.00 (12) 0.5 (2) 1.5 -3.710 .000 -0.83 
Self-report subscale scores 1.5 (3) 0 (0) 20.00 -2.799 .005 -0.63 
Informant-rating subscale scores 11.5 (10) 0.5 (2) 1.5 -3.710 .000 -0.83 
   
Internal consistency  
The GPS-ID total score was found to have excellent internal consistency when administered to both 
groups (α=0.91, n=20); with a range for the total scale, as measured by alpha if item-deleted, 
between 0.897 and 0.915.  When administered to only the psychosis group, internal consistency 
remained satisfactory (α=0.81, n=10); with a range for the total scale, as measured by alpha if item-
deleted, between 0.784 and 0.836.   
   
Sensitivity and Specificity 
A total GPS-ID score of ≥4 yielded high sensitivity (90%) and specificity (100%).  Sensitivity and 
specificity was found to be the same for the informant rating subscale with a cut-off of ≥4 yielding 
90% sensitivity and 100% specificity.  The self-report subscale was also investigated, and a cut-off 
score of ≥1 yielded a sensitivity of 60% and a specificity of 100% (Figure 3).      
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5.4 Reliability 
Inter-test reliability between the self-report subscale and the informant-rating subscale was found to 
be high for both groups together (rho=.780, p=.000) and the psychosis group (rho=.824, p=.003). 
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Figure 2 ROC curves for total GPS-ID score, self-report subscale and informant-rating subscale 
Figure 1 Comparison of GPS-ID total scores (mean ±SE) for psychosis and non-psychosis groups 
Figure 1 Comparison of GPS-ID total scores for psychosis and non-psychosis groups 
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6. Discussion 
There is a clear need for a psychosis screening tool that has been developed specifically for the mild to 
moderate adult ID population.  Preliminary evidence suggests the GPS-ID may fulfil this need, although 
further testing is required.  The GPS-ID was found to have satisfactory psychometrics, in terms of 
face/content validity; discriminant validity; internal consistency (α=0.91); and sensitivity (90%) and 
specificity (90%).  Criterion validity was not supported, and test-retest reliability was not investigated. 
The methodology employed supports the validity of this measure.  However, it was noted that 12 
items scored ‘0’ for over half the psychosis group.  This could suggest the item content did not appropriately 
describe participant’s experiences.  However, it was not expected that all participants would score on all 
items. Furthermore, not all psychosis group participants were experiencing psychotic symptoms at 
interview, despite having a psychotic illness and being referred into the study as having active symptoms.  
Considering the small sample size (n=10), it is unlikely that all items would receive a positive score for all 
participants.  Moreover, none of the 23 items scored ‘0’ for every psychosis group participant, suggesting 
that the tool describes a wide range of experiences that can manifest in adults with ID and psychosis.  
Further investigation with a larger sample size is required in order to make more conclusive judgements 
about the content validity of the GPS-ID.     
 Investigation into the criterion validity of the GPS-ID yielded a small to moderate, albeit non-
significant relationship between the GPS-ID and PSYRATS total scores.  However, the lack of significant 
correlation may be attributable to other factors, rather than indicating a true lack of criterion validity.  First, 
the GPS-ID scores symptoms occurring within the past four weeks, whereas the PSYRATS scores only 
symptoms present during the past week.  Therefore, a participant experiencing symptoms during the past 
month but not the past week, would score on the GPS-ID, but not the PSYRATS.  Second, the GPS-ID screens 
for a range of psychotic experiences including visual hallucinations and negative symptoms; whereas the 
PSYRATS scores only auditory hallucinations and delusions.  Therefore, someone experiencing negative 
symptoms would score on the GPS-ID, but not the PSYRATS.  In retrospect, the PSYRATS may not have been 
an optimum comparator; however, in the initial planning of the study it was deemed the best choice of the 
only two general population psychosis screening tools that have been tested in the ID population.  Third, 
given that the majority of the non-psychosis group did not have additional mental health problems, it is 
possible that the GPS-ID detected emotional distress rather than psychotic symptoms, which could account 
for the lack of significant relationship between the GPS-ID and the PSYRATS total scores.  Finally, the lack of 
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correlation between the two tools may be due to the small sample size.  Further investigation with a larger 
sample size and a control group of adults with ID and other mental health problems would allow for more 
conclusive judgements to be made.     
 High levels of discriminant validity were demonstrated for the GPS-ID.  However, the majority of 
participants in the non-psychosis group did not have a mental health problem.  Future research is needed to 
determine whether the GPS-ID can discriminate between adults with ID and psychosis, and adults with ID 
and other mental health problems, particularly affective disorders.  This is important given the high 
prevalence of mental health problems in this population (Cooper et al. 2007)   
Internal consistency was found to be high when calculated for both groups together and the 
psychosis group alone, suggesting that the items are measuring the same construct.  Investigations into the 
sensitivity and specificity of the GPS-ID suggest that the tool may be used flexibly, according to clinical need. 
Sensitivity and specificity were found to be high for both the GPS-ID total score and the informant-rating 
subscale (with a cut-off score of ≥4 yielding 90% sensitivity and 100% specificity).  Similarly, specificity 
remained high at 100% for the self-report subscale, but sensitivity reduced to 60% (for a cut-off score of ≥1).  
Therefore, the self-report scale can also be used as a standalone screen to exclude those without psychosis.  
When employing cut-off scores achieving 100% specificity, it is recommended that participants scoring 
above the thresholds receive further assessment.   
In comparison with the PSYRATS and the PANSS (Hatton et al. 2005), the GPS-ID appears to perform 
well.  It shows similar rates of internal consistency to the PSYRATS, and higher rates than the PANSS.  The 
PSYRATS and PANSS showed discriminant validity for the auditory hallucinations subscale and positive 
symptoms subscale, respectively.  However, the PSYRATS delusions subscale and the PANSS negative 
symptoms subscale failed to discriminate between the psychosis, other mental health and no psychosis 
groups.  None of the psychosis group participants scored on the PSYRATS delusions subscale, despite some 
reporting delusional beliefs during the initial PAS-ADD Checklist screening.  This suggests that the PSYRATS 
may not be accessible to individuals with ID.  Rates of sensitivity and specificity were not reported for the 
PSYRATS and the PANSS, preventing further comparison.   
 The GPS-ID took on average 15-30 minutes to administer, varying with participants’ ability and 
severity of symptoms.  Generally, participants had no difficulties answering the self-report questions.  
However, some psychosis group participants required prompting from their carers to describe their 
symptoms.  One such individual found it less distressing to shake or nod their head, rather than verbally 
acknowledging auditory hallucinations.  One psychosis participant with a moderate ID was able to complete 
48 
 
the self-report questions (using the visual aid) but was unable to complete the PSYRATS.  This suggests that 
the GPS-ID may be more accessible to those with more severe ID and psychosis than the PSYRATS.  However, 
further testing with a larger sample would be required to determine this supposition.  For the non-psychosis 
group, some participants described non-psychotic experiences in relation to self-report questions.  For 
example, one participant reported auditory hallucinations, but further investigation revealed that they were 
referring to traffic noise.  When asked ‘Has anyone been picking on you or getting at you’, several 
participants talked about being bullied.  This may be a common response given that most adults with ID 
experience bullying during their childhood (Mencap, 2007).  However, it was quickly established that 
participants were not describing psychotic experiences.  Similarly, carers had no difficulties responding to 
the informant-rating subscale.  Several in the non-psychosis group reported that participants had ‘been 
talking to themselves’, but further investigation revealed that this was often soliloquy or self-reassurance.  
Given that responses often require further investigation, it is recommended that the GPS-ID is administered 
only by clinicians with a knowledge of psychosis in this population, and in strict adherence to the 
instructions for use.       
Despite the high rates of sensitivity and specificity found for a cut-off score of ≥4, caution should be 
taken when interpreting scores as the GPS-ID is not a diagnostic tool, and.  It is imperative that all adults 
meeting or exceeding the cut-off score of ≥4 receive further assessment, to avoid any unnecessary and 
potentially harmful treatment.  Furthermore, it is possible that this cut-off score can be met without any 
positive scoring on the self-report scale.  Although some individuals with psychosis will be unwilling or 
unable to report their symptoms, it is difficult to accurately detect psychosis without such a self-report of 
internal experience.  It is therefore suggested that scores meeting the cut-off without a positive self-report 
score are viewed with caution, and clinicians should consider other possible causes of the observed 
behaviours.  It is recommended that the informant-rating subscale may have more utility in the monitoring 
of symptoms in those already known to have a diagnosis of psychosis.  Equally, given the abstract nature of 
the self-report questions, some adults may report experiences which appear to be, but are not in fact 
psychotic in nature.  Hence, care must be taken to fully understand the experience that is being reported, so 
as not to increase the likelihood of false-positives.           
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6.1 Limitations 
First, only three adults with ID participated in the focus groups, along with four relatives/workers.  Original 
intentions were to recruit a total of six to 10 people for the focus groups.  However, recruitment proved 
challenging, with Health and Social workers concerned that potential participants were either too unwell or 
lacking the necessary communication skills to attend focus groups.  Given the small number who 
participated, the experiences reported may not be representative of the wider population of adults with ID 
and psychosis.  Some attempt was made to counteract this limitation, through obtaining clinical input from 
inpatient Learning Disability Nurses with several years’ experience working with people with ID and 
psychosis.  Given that psychosis is estimated to be less prevalent than affective disorders in the ID 
population (4.4% vs. 6.6%; Cooper et al. 2007), this may explain why it was not possible to recruit numbers 
equivalent to those reported by the GAS-ID and GDS-LD studies.  Second, due to the small sample size, it was 
not possible to show criterion validity of the GPS-ID; and as previously noted, not all psychosis group 
participants had active psychotic symptoms at interview.  It was originally intended that adults without ID 
and psychosis would be recruited to test criterion validity; however, due to time constraints this step was 
omitted.  Third, it was originally intended that following expert feedback, a draft GPS-ID would be piloted 
with people with ID and psychosis, allowing one final iteration of refinement.  However, time constraints 
prevented this step, which would likely have increased the face validity of the tool.  Instead, participants 
were asked for their views after interview; however, their responses were limited, and perhaps less 
informative than if a more structured approach had been taken.  Fourth, the interviewer was not blinded to 
participant groups, and this may have impacted completion of the questionnaires.  Fifth, due to time 
constraints, test-retest reliability of the GPS-ID could not be investigated.  Finally, two adults with a 
borderline level of ID participated in the study.  They were invited by health care workers, who later 
reported that they had borderline ID.  These participants were not subsequently excluded because they 
were not from the same group (and hence their abilities were matched between groups); and it was viewed 
as unethical to exclude them after they had given up their time to participate. 
 
6.2 Future research 
Initial findings of the utility of the GPS-ID are promising, however future research is needed to both replicate 
and further investigate its psychometric properties.  Such studies should recruit a larger sample of adults 
with ID and psychosis, so that content validity can be further investigated.  Structured feedback from 
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participants and their carers regarding the tool would also be beneficial.  Construct validity could also be 
further tested with a larger sample, and researchers may consider recruiting general population adults with 
psychosis for this purpose.  Future studies should recruit a comparison group of adults with ID and a range 
of affective disorders in order to further assess the discriminant properties of the tool.  It may also be 
beneficial to consider a different tool for comparison purposes such as the PANSS (Kay et al. 1989) which 
may share more constructs with the GPS-ID than the PSYRATS.   Furthermore, interviewers should be 
blinded to participant’s mental health, and test-retest reliability should be investigated.  
     
6.3 Clinical implications 
Preliminary investigations suggest the GPS-ID is accessible for adults with mild to moderate ID and 
psychosis.  High levels of sensitivity and specificity were found for the total score, self-report and informant-
rating subscales, suggesting that the tool can be used flexibly.  It takes 15-30 minutes to complete and can 
exclude those without psychosis and identify those likely to have psychosis, and thus requiring further 
assessment.  It also fulfils a clinical need, given that no other psychosis screening tool has been developed 
specifically for the adult ID population.   
7. Conclusions 
The GPS-ID was found to have a range of acceptable psychometric properties, including face/content 
validity, discriminant validity, internal consistency and sensitivity and specificity.  Further research is needed 
to replicate the reported psychometric properties, and to investigate those which could not be fully assessed 
due to sample size and time constraints.    
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Chapter 3: Appendices 
Appendix 1 – Author guidelines  
Journal of Intellectual Disability Research  
 
ETHICAL GUIDELINES 
The Journal of Intellectual Disability Research adheres to the ethical guidelines for publication and 
research summarised below.  
 
Authorship and Acknowledgements 
Authorship: Authors submitting a paper do so on the understanding that the manuscript has been 
read and approved by all authors and that all authors agree to the submission of the manuscript to 
the journal. ALL named authors must have made an active contribution to the conception and 
design and/or analysis and interpretation of the data and/or the drafting of the paper and ALL must 
have critically reviewed its content and have approved the final version submitted for publication. 
Participation solely in the acquisition of funding or the collection of data does not justify authorship 
and, except in the case of complex large-scale or multi-centre research. 
 
The Journal of Intellectual Disability Research adheres to the definition of authorship set up by The 
International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship 
criteria should be based on 1) substantial contributions to conception and design of, or acquisition 
of data or analysis and interpretation of data, 2) drafting the article or revising it critically for 
important intellectual content and 3) final approval of the version to be published. Authors should 
meet conditions 1, 2 and 3. 
 
It is a requirement that all authors have been accredited as appropriate upon submission of the 
manuscript. Contributors who do not qualify as authors should be mentioned under 
Acknowledgements. 
 
Acknowledgements: Under Acknowledgements please specify contributors to the article other 
than the authors accredited. Please also include specifications of the source of funding for the study 
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and any potential conflict of interests if appropriate. Suppliers of materials should be named and 
their location (town, state/county, country) included. 
 
Ethical Approvals 
Experimental Subjects: experimentation involving human subjects will only be published if such 
research has been conducted in full accordance with ethical principles, including the World Medical 
Association Declaration of Helsinki (version, 2002 www.wma.net/e/policy/b3.htm) and the additional 
requirements, if any, of the country where the research has been carried out. Manuscripts must be 
accompanied by a statement that the research was undertaken with the understanding and written 
consent of each participant and according to the above mentioned principles. A statement regarding 
the fact that the study has been independently reviewed and approved by an ethical board should 
also be included. Editors reserve the right to reject papers if there are doubts as to whether 
appropriate procedures have been used. 
 
All studies using human participants or animal subjects should include an explicit statement in the 
Material and Methods section identifying the review and ethics committee approval for each study, if 
applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate 
procedures have been used. 
 
Ethics of investigation: Papers not in agreement with the guidelines of the Helsinki Declaration as 
revised in 1975 will not be accepted for publication. 
 
Permissions 
 
If all or parts of previously published illustrations are used, permission must be obtained from the 
copyright holder concerned. It is the author's responsibility to obtain these in writing and provide 
copies to the Publishers. 
 
Copyright Assignment 
If your paper is accepted, the author identified as the formal corresponding author for the paper will 
receive an email prompting them to login into Author Services; where via the Wiley Author Licensing 
56 
 
Service (WALS) they will be able to complete the license agreement on behalf of all authors on the 
paper. 
For authors signing the copyright transfer agreement 
If the OnlineOpen option is not selected the corresponding author will be presented with the 
copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed 
in the samples associated with the Copyright FAQs below: 
CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp 
 
MANUSCRIPT TYPES ACCEPTED 
 
Original Research Article The main text should proceed through sections of Abstract, 
Background, Methods, Results, and Discussion. Reports of up to 4,500 words are suitable for major 
studies and presentation of related research projects or longitudinal enquiry of major theoretical 
and/or empirical conditions. Please note that articles exceeding 4,500 words will be unsubmitted 
immediately from the review process and the authors will be asked to reduce the length of the 
article. 
Authors submitting articles should be guided by the following checklists prior to submission: 
  
For observational studies: http://www.strobe-statement.org/?id=available-checklists 
For diagnostic studies: (http://www.stard-statement.org/checklist_maintext.htm) 
   
Systematic Reviews of up to 4,500 words are suitable for submission.  Authors submitting a 
systematic review are encouraged to assess the quality of their article against the PRISMA checklist 
prior to submission (http://www.prisma-statement.org/2.1.2%20-
%20PRISMA%202009%20Checklist.pdf) or MOOSE guideline (insert link to MOOSE PdF).  Further 
details on systematic reviews can be obtained from Prof. Richard Hastings (Editor); email: 
R.Hastings@warwick.ac.uk 
 
MANUSCRIPT FORMAT AND STRUCTURE 
5.1. Format 
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Language: The language of publication is English. Authors for whom English is a second language 
must have their manuscript professionally edited by an English speaking person before submission 
to make sure the English is of high quality. It is preferred that manuscripts are professionally edited. 
A list of independent suppliers of editing services can be found at 
http://authorservices.wiley.com/bauthor/english_language.asp . All services are paid for and 
arranged by the author and use of one of these services does not guarantee acceptance or 
preference for publication. 
 
Abbreviations, Symbols and Nomenclature: Spelling should conform to The Concise Oxford 
Dictionary of Current English and units of measurements, symbols and abbreviations with those in 
Units, Symbols and Abbreviations (1977) published and supplied by the Royal Society of Medicine, 
1 Wimpole Street, London W1M 8AE. This specifies the use of SI units. 
 
It is important that the term 'intellectual disabilities' is used when preparing manuscripts. Please 
note that 'intellectual disability', as used in the journal, includes those conditions labelled mental 
deficiency, mental handicap, learning disability and mental retardation in some counties. The term 
‘person’, ‘people’ or ‘participant(s)’ should be used as opposed to ‘patient(s)’. 
  
A high proportion of papers are submitted with the term ‘behavior’ as opposed to ‘behaviour’; please 
use ‘behaviour’. 
  
Where applicable the journal standard is to use words ending in –ise as opposed to –ize. For 
example, use ‘analyse’ ‘standardise’ as opposed to ‘analyze’ and ‘standardize’ 
  
 
5.2. Structure 
All manuscripts submitted to The Journal of Intellectual Disability Research should include: Title, 
Keywords, structured Abstract, Main Text (divided by appropriate sub headings) and References. 
 
Title Page: Please remember that peer-review is double-blind, so that neither authors nor 
reviewers know each others' identity. Therefore, no identifying details of the authors or their 
institutions must appear in the submitted manuscript; author details should be entered as 
part of the online submission process. However, a 'Title Page' must be submitted as part of the 
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submission process as a 'Supplementary File Not for Review'. This should contain the title of the 
paper, names and qualifications of all authors, their affiliations and full mailing address, including e-
mail addresses and fax and telephone numbers. 
 
Keywords: The author should also provide up to six keywords to aid indexing.  Please think 
carefully about the keywords you choose as this will impact on the likelihood of your article being 
located during literature searches (https://authorservices.wiley.com/bauthor/seo.asp). 
 
Abstracts: For full and brief reports, and reviews, a structured summary should be included 
at the beginning of each article, incorporating the following headings: Background, Method, 
Results, and Conclusions.  These should outline the questions investigated, the design, essential 
findings, and the main conclusions of the study. 
 References  The Journal follows the Harvard reference style. References in text with more than two authors should be abbreviated to (Brown et al. 1977). Authors are responsible for the accuracy of their references.  The reference list should be in alphabetical order thus: 
·         Giblett E.R. (1969) Genetic Markers in Human Blood. ·         Blackwell Scientific Publications, Oxford. 
·         Moss T.J. & Austin G.E. (1980) Preatherosclerotic lesions in Down's syndrome. Journal of 
Mental Deficiency Research 24, 137- 41. 
·         Seltzer M. M. & Krauss M.W. (1994) Aging parents with co-resident adult children: the impact of 
lifelong caregiving. In: Life Course Perspectives on Adulthood and Old Age (eds M. M. Seltzer, 
M.W. Krauss & M. P. Janicki), pp. 3–18. American Association on Mental Retardation, 
Washington, DC. 
Where more than six authors are listed for a reference please use the first six then 'et al.' 
 
The Editor and Publisher recommend that citation of online published papers and other material 
should be done via a DOI (digital object identifier), which all reputable online published material 
should have - see www.doi.org/ for more information. If an author cites anything which does not 
have a DOI they run the risk of the cited material not being traceable. 
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We recommend the use of a tool such as EndNote or Reference Manager for reference 
management and formatting. 
EndNote reference styles can be searched for here: www.endnote.com/support/enstyles.asp 
Reference Manager reference styles can be searched for 
here:www.refman.com/support/rmstyles.asp 
5.4. Tables, Figures 
 
Tables: Tables should include only essential data. Each table must be typewritten on a separate 
sheet and should be numbered consecutively with Arabic numerals, e.g. Table 1, Table 2, etc., and 
give a short caption. 
 
Figures: All graphs, drawings and photographs are considered figures and should be numbered in 
sequence with Arabic numerals. All symbols and abbreviations should be clearly explained. 
Tables and figures should be referred to in the text together with an indication of their approximate 
position recorded in the text margin. 
 
Figure Legends: In the full-text online edition of the Journal, figure 
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Appendix 2 – Systematic review searches and quality ratings 
Appendix 2.1 Search strategy according to database 
Table 1 Ovid Medline search strategy 
Search 
number 
Search terms Search 
results 
1 exp Intellectual Disability/ 86342 
2 (intellec* disab* or learning disab* or mental* retard* or learning impair* 
or mental* handicap*).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
80358 
3 exp Mentally Disabled Persons/ 2310 
4 1 or 2 or 3 114219 
5 exp Psychosis/ 41277 
6 exp schizophrenia/ 91673 
7 (psychotic disorders or psychosis or psychoses or psychotic$ or psychos$ 
or schizophrenia or schizo$ or schizoaffective or schizoaffective disorder or 
delusional disorder$).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, 
unique identifier] 
285640 
8 5 or 6 or 7 285790 
9 exp prevalence studies/ 212306 
10 prevalence.mp. or Prevalence/ 
(prevalence or prevalence rate$ or morbidity).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier] 
781927 
11 9 or 10 931796 
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12  4 and 8 and 11 
 
473 
 
 
 
Table 2 Ovid Embase search strategy 
Search 
number 
Search terms Search 
results 
1 exp mental deficiency/ 139767 
2  limit 1 to abstracts 
 
96356 
3 (intellec* disab* or learning disab* or mental* retard* or learning impair* 
or mental* handicap*).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
73092 
4 limit 3 to abstracts 62901 
5 2 or 4 122718 
6 exp Psychosis/ 256972 
7 (psychotic disorders or psychosis or psychoses or psychotic$ or psychos$ 
or schizophrenia or schizo$ or schizoaffective or schizoaffective disorder or 
delusional disorder$).mp. [mp=title, abstract, heading word, drug trade 
name, original title, device manufacturer, drug manufacturer, device trade 
name, keyword] 
437871 
8 6 or 7 463014 
9 (prevalence or prevalence rate$ or morbidity).mp. [mp=title, abstract, 
heading word, drug trade name, original title, device manufacturer, drug 
manufacturer, device trade name, keyword] 
1149878 
10 5 and 8 and 9 920 
 
Table 3 PSYCInfo search strategy 
Search 
number 
Search terms Search options Search 
results 
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1 DE "Intellectual Development Disorder" OR DE 
"Learning Disabilities"  
Search modes - 
Boolean/Phrase 
58951 
2 DE "Schizophrenia" OR DE "Schizophrenia 
(Disorganized Type)" OR DE "Acute Psychosis" OR 
DE "Paranoid Schizophrenia" OR DE "Fragmentation 
(Schizophrenia)" OR DE "Catatonic Schizophrenia" 
OR DE "Acute Schizophrenia" OR DE "Psychosis" OR 
DE "Paranoia (Psychosis)" OR DE "Schizoaffective 
Disorder"  
Search modes - 
Boolean/Phrase 
95570 
3 TX prevalence or prevalence rate$ or morbidity Search modes - 
Boolean/Phrase 
105082 
4 S1 AND S2 AND S3  Search modes - 
Boolean/Phrase 
46 
 
Table 4 PubMed search strategy 
Search 
number 
Search terms Search 
results 
1 Search intellectual disability[MeSH Terms] 84517 
2 Search psychosis[MeSH Terms] 44216 
3 Search schizophrenia[MeSH Terms] Sort by: Author 90117 
4 Search (schizophrenia[MeSH Terms]) OR psychosis[MeSH Terms] Sort by: Author 124018 
5 
Search (intellectual disability[MeSH Terms]) AND ((schizophrenia[MeSH Terms]) OR 
psychosis[MeSH Terms]) 1622 
6 
Search (prevalence[Text Word] OR prevalence rate$[Text Word] OR morbidity[Text 
Word]) 769931 
7 
Search (((intellectual disability[MeSH Terms]) AND ((schizophrenia[MeSH Terms]) 
OR psychosis[MeSH Terms]))) AND ((prevalence[Text Word] OR prevalence 
rate$[Text Word] OR morbidity[Text Word])) Sort by: Author 105 
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Appendix 2.2 Excluded papers 
Table 5 Details of excluded papers 
Excluded 
studies 
Author Reason for exclusion 
1.  Heaton-Ward (1977) Hospital sample 
2.  Monfils & Menolascino (1983) Sample of patients using specialist psychiatric 
services for people with ID 
3.  Reid (1994) Hospital sample 
4.  Cherry et al. (1997) Residential sample 
5.  Tsakanikos et al. (2006) Sample of patients using specialist psychiatric 
services for people with ID 
6.  Bhaumik et al. (2008) Sample of patients using specialist psychiatric 
services for people with ID 
7.  Reid (1989) Review paper 
8.  Campbell & Malone (1991) Review paper 
9.  Vitiello & Behar (1992) Review paper 
10.  Reid (1993) Review paper 
11.  Azam et al. (2009) Review paper 
12.  Dyggve & Kodahl (1979)  Included children ≤15 years – not possible to 
calculate results for those aged ≥16 years 
13.  Kishore et al. (2004) Included children ≤15 years – not possible to 
calculate results for those aged ≥16 years 
14.  Kishore et al. (2005) Included children ≤15 years – not possible to 
calculate results for those aged ≥16 years 
15.  White et al. (2005) Included children ≤15 years – not possible to 
calculate results for those aged ≥16 years 
16.  Myrbakk & von Tetzchner 
(2008) 
Included children ≤15 years – not possible to 
calculate results for those aged ≥16 years 
17.  Pasamanick (1961) General population 
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18.  Astrup (1989) General population 
19.  Hagnell et al. (1994) General population – results of ID population 
reported in Nettelbladt et al. (2009) 
20.  Noorbala et al. (2004) General population 
21.  Patel et al (2007) General population 
22.  Chaplin et al. (1996) Included adults with borderline ID – not possible to 
calculate results for those with mild to profound ID. 
23.  Hassiotis et al. (2008) Included adults with borderline ID – not possible to 
calculate results for those with mild to profound ID. 
24.  Morgan et al. (2008). Included adults with borderline ID – not possible to 
calculate results for those with mild to profound ID. 
25.  Salvador-Carulla et al. (2000) Same data reported in other included study - 
Salvador-Carulla et al. (1998) 
26.  Kozlowski et al. (2011) Prevalence of psychosis not reported  
 
 
Appendix 2.3 Quality ratings  
Table 6 Quality rating criteria 
Domain Criteria Rating 
Sample size >100 2 
 30-100 1 
 <30 0 
Representativeness 
of sample 
Population based  2 
Administrative  1 
 All other 0 
Reporting of level of 
ID 
Distribution of ID reported  0/1 
Method of 
assessment 
Clinical diagnosis by a psychiatrist or psychologist based on 
standard diagnostic system 
2 
Clinical diagnosis by a psychiatrist or psychologist 1 
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Other psychosis screening instrument used 1 
All other 0 
  
Report of precision 
estimate 
Conﬁdence interval is reported   0/1 
 
Table 7 Quality ratings for included studies 
Study Sample 
size 
Representativeness 
of sample 
Reporting 
of level of 
ID 
Method of 
assessment 
Report on 
measure of 
variability 
Total 
score 
Göstason (1985) 2 2 1 2 0 7 
Lund (1985) 2 2 1 1 0 6 
Cooper (1997) 2 2 0 2 0 6 
Salvador-Carulla 
et al (1998) 
2 0 1 2 0 5 
Deb et al (2001) 1 1 1 2 1 6 
Holden & 
Gitlesen (2003) 
2 1 1 0 0 4 
Holden & 
Gitlesen (2004) 
1 1 1 1 0 4 
Taylor et al 
(2004) 
2 1 0 0 1 4 
Bailey (2007) 2 1 0 2 0 5 
Cooper et al 
(2007) 
2 2 1 2 1 8 
Nettelbladt et al 
(2009) 
1 2 1 0 0 4 
Sheehan et al 
(2015) 
2 2 0 0 0 4 
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Appendix 3 – Psychometric properties of existing measures 
Appendix 3.1 Psychometric properties of ID screening tools 
Table 8 Psychometric properties of depression and anxiety screening tools developed for the ID population  
Study/measure Psychometric property Value/evidence 
Cuthill et al. (2003) 
GDS-LD 
Three groups of 
participants: 
ID depression = 19 
ID no depression = 19 
Non-ID depression = 27 
 
Face/content validity Method employed; no items scored 0 for >half 
of depression group 
Criterion validity 
(n=27) 
 
r=0.94, p<.001 
Discriminant validity 
(n=65) 
Significant difference between group scores 
where p<.05 
Internal consistency 
(n=38) 
(n=19) 
 
α=0.90 
α=0.81 
Test-retest reliability 
(n=38) 
(n=19) 
 
r=0.97, p<.001 
r=0.94, p<.001 
Sensitivity 
(n=38) 
 
96% 
Specificity 
(n=38) 
 
90% 
   
Mindham & Espie (2003) 
GAS-ID 
Three groups of 
participants: 
ID anxiety = 19 
ID no anxiety = 16 
Non-ID anxiety = 19 
 
Face/content validity Method employed 
Criterion validity 
(n=19) 
 
ρ=0.75, p<.001 
Discriminant validity 
(n=54) 
Significant difference between group scores 
where p<.05 
Internal consistency 
(n=35) 
 
α=0.96 
Test-retest reliability 
(n=17) 
 
r=0.95, p<.0001 
Sensitivity 
(n=36) 
100% 
Specificity 
(n=36) 
100% 
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Appendix 3.2 Psychometric properties of ID screening tools 
Table 9 Psychometric properties of psychosis screening tools developed for the general population  
Study/measure Psychometric property Value/evidence 
Hatton et al. (2005) 
PSYRATS 
Three groups of ID 
participants: 
Psychosis n=11 
Other mental health n=14 
No mental health n=37 
Face/content validity Not relevant to study 
Criterion validity 
(n=62) 
PSYRATS auditory hallucinations subscale 
correlated with PANSS positive symptoms 
r=0.45, p<.001 
Discriminant validity 
(n=62) 
No significant difference between groups on 
delusions subscale where p=.52 
Significant difference between groups on 
auditory hallucinations subscale where p<.001 
Internal consistency 
(n=62) 
Delusions subscale - α=0.94 
Auditory hallucinations subscale - α=0.88 
Test-retest reliability 
(n=10) 
Delusions subscale – not tested 
Auditory hallucinations subscale - rho=0.99, 
p=.001 
Sensitivity Not reported 
Specificity Not reported 
   
Hatton et al. (2005) 
PANSS 
Three groups of ID 
participants: 
Psychosis n=11 
Other mental health n=14 
No mental health n=37 
Face/content validity Not relevant to study 
Criterion validity 
(n=62) 
PSYRATS auditory hallucinations subscale 
correlated with PANSS positive symptoms 
r=0.45, p<.001 
Discriminant validity 
(n=62) 
Significant difference between groups on 
positive symptoms subscale where p=.001 
No significant difference between groups on 
negative symptoms subscale where p=.55 
Significant difference between groups on 
general symptoms subscale where p=.03 
Internal consistency 
(n=62) 
Positive symptoms - α=0.62 
Negative symptoms - α=0.68 
General symptoms - α=0.70 
Test-retest reliability 
(n=10) 
Positive symptoms - rho=0.89, p=.001 
Negative symptoms - rho =0.92, p=.001 
General symptoms - rho =0.47, p=.18 
68 
 
Sensitivity Not reported 
Specificity Not reported 
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Appendix 4 – Major research proposal 
Development of a psychosis screening tool for use in adults with 
intellectual disabilities 
Abstract  
Background  
Psychosis has been found to have a higher prevalence in the intellectually disabled population than 
the general population.  However, there are currently no screening measures which have been 
developed specifically for use in the intellectually disabled population.  Some general population 
screening tools have been found to have adequate reliability in the ID population, but there is some 
evidence suggesting such tools may have poor sensitivity.    
Aims  
To develop a measure for screening psychosis that is appropriate for use in the mild to moderate ID 
population. 
Methods  
Items will be pooled from existing measures and diagnostic criteria, and presented to focus groups 
of adults with ID and psychosis and their carers.  Items will be refined according to focus group input 
and a draft scale will be compiled.  The measure will then be used to interview two groups of 
participants: adults with ID and active psychosis, and adults with ID without psychosis.  All 
participants will also be interviewed with The Psychotic Symptom Rating Scales PSYRATS. The 
psychometric properties of the measure will then be investigated.  Should they wish to do so, adults 
with ID and psychosis will then be given the opportunity to provide any feedback they may have on 
the new tool.     
Applications  
The resulting measure may help with the identification, diagnosis and trajectory of psychotic illness 
in people with intellectual disabilities. 
Introduction  
Research has found the point prevalence of psychosis in adults with intellectual disability (ID) to 
range from 0.8-5.0% (Lund, 1985; Deb et al. 2001; Bailey, 2007; Cooper et al. 2007).  Prevalence 
rates of psychosis have also varied in the general population, with estimates ranging from 0.4-1.2% 
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(Jenkins et al, 1997; Brugha et al. 2005; Wittchen et al. 2011).  Thus it appears that the prevalence of 
psychosis is much higher in the ID population than the general population.  Given this higher 
prevalence, it is surprising that there is currently no psychosis screening tool designed specifically for 
use within the ID population.     
Several general psychopathology screening tools have been developed specifically for use in the ID 
population, some of which comprise items or subscales that screen for psychosis (for example, the 
Psychopathology Instrument for Mentally Retarded Adults (PIMRA; Matson et al. 1984) and the 
Psychiatric Assessment Schedule for use in Adults with Developmental Disabilities (PAS-ADD; Moss 
et al. 1998).  However, the use of psychopathology screening tools in identifying psychosis is 
problematic.  These scales were derived from general population criteria, such as the Diagnostic and 
Statistical Manual of Mental Disorders 3rd Edition (DSM-III; American Psychiatric Association, 1980) 
and The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research 
(ICD-10; World Health Organization, 1993).  Such general population nosology have been shown by 
some researchers to be unable to accommodate the pathoplastic effects of ID, and thus their 
application result in under-recognition of psychiatric illness in people with ID (S.-A. Cooper et al., 
2007).  This under-recognition has been shown specifically in relation to diagnosis of psychosis when 
using the PAS-ADD Checklist.  The PAS-ADD Checklist employs the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN; WHO, 1994) algorithm, which assigns diagnoses according to strict 
application of ICD-10 research criteria.  Moss et al (1996) investigated the validity of diagnosing 
schizophrenia according to the PAS-ADD Checklist, and found that it failed to recognise 25% of 
people with a clinical diagnosis of schizophrenia.  The researchers noted that although the PAS-ADD 
Checklist scores did not translate to an ICD-10 diagnosis, the participants exhibited clear psychotic 
symptoms.    
More recently, researchers have attempted to develop scales for specific psychiatric disorders in the 
ID population which address the aforementioned issue.  For example, the Glasgow Depression Scale 
for people with a Learning Disability (GDS-LD) considered symptomatology included in both general 
population criteria (the ICD-10) and criteria designed specifically for use in the ID population (the 
diagnostic criteria for psychiatric disorders for use with adults with learning disabilities/mental 
retardation (DC-LD); Royal College of Psychiatrists, 2001). Focus groups of adults with ID were also 
consulted, and the resulting 20-item screen was found to have good test-retest reliability (r=0.97) 
and internal consistency (Cronbach’s α=0.90), with high sensitivity (96%) and specificity (90%) 
(Cuthill, Espie, & Cooper, 2003).  
Currently, there have been no such attempts to develop specific psychosis scales according to DC-LD 
criteria.  There have however been investigations into the use of general psychotic rating scales.  For 
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example, the Positive and Negative Syndrome Scale (PANSS; Kay, Opler, & Lindenmayer, 1989) and 
the Psychotic Symptom Rating Scales (PSYRATS; Haddock, McCarron, Tarrier, & Faragher, 1999) have 
been reported to show adequate reliability and validity within a sample of 62 adults with mild ID 
(Hatton et al., 2005).  The participants in this study were recruited from two sites: in one site, 
specialist psychiatrists selected potential participants based on clinical judgement according to ICD-
10 criteria; in the other site, potential participants were selected on the basis of a large scale PAS-
ADD Checklist population screening.  Although the researchers reported adequate psychometric 
properties, they suggested that further investigation was necessary, particularly regarding 
applicability of items concerning negative symptoms and delusions.  This has been an area for 
contention, with some suggestion that the profile of psychotic disorders may be different in people 
with ID than the general population (Hatton et al., 2005).  The Hatton et al study (2005) used general 
population diagnostic criteria to both select their sample and diagnose psychosis.  Therefore, it is 
possible that individuals presenting with an atypical profile would not have been identified as having 
psychosis.   
Hence, the use of both general population psychosis screening tools and ID psychopathology 
screening tools may lead to under recognition of psychosis in people with ID.  This seems 
counterintuitive to current Scottish policy regarding ID, which aims include “ensuring that services 
are fully tailored to individual needs” (COSLA foreword; The Scottish Government, 2013).  Thus, it 
seems there is a need to develop a psychosis rating scale for use in the ID population.     
 
Aims and hypotheses  
Aims 
To develop a screening measure for psychosis that is appropriate for use in the mild to moderate ID 
population. 
Hypotheses  
The resulting scale will have acceptable psychometric properties which are similar to those of 
existing screening measures developed for use with the ID population ( such as the GDS-LD (Cuthill 
et al., 2003) and the GAS-ID (Mindham & Espie, 2003)). 
 discriminant validity: effect size f=0.4 
 criterion validity: r≥0.75 
 test re-test reliability: r≥0.70 
 internal consistency:  α≥0.70 
 sensitivity: ≥ 70% 
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 specificity: ≥ 70% 
Plan of Investigation  
Participants  
Focus groups 
Participants will include adults with ID who are accessing learning disability community 
mental health services, and their paid or family carers.  If they prefer, the adults with ID may 
attend the focus group without a paid or family carer.  Only paid or family carers of a person 
who wishes to take part in the focus group and wants their paid or family carer to go with 
them will be invited.   
Field test groups 
Participants will include adults who are accessing learning disability community or inpatient 
mental health services. 
Participants who attend the focus group may also take part in the field test groups.   
Inclusion and Exclusion Criteria  
Inclusion criteria 
Focus groups 
 Adults aged ≥16 with a mild to moderate ID who have reasonable verbal 
communication i.e. are able to express themselves, and diagnosis of psychosis. 
 Family or paid carers of adults with mild to moderate ID who have a diagnosis of 
psychosis and wish to take part in the focus group. 
Field test groups 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, a diagnosis of psychosis, and are currently experiencing psychosis. 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, and do not have a diagnosis of psychosis. 
Exclusion criteria 
 Adults with a diagnosis of autism. 
 Adults with a diagnosis of dementia. 
 Adults with severe and profound ID. 
Recruitment Procedures  
Recruitment will be conducted in two waves: focus group, then field test participants.  Participants 
will be recruited from learning disability community and inpatient mental health services.    
Information regarding the purpose of the study and inclusion/exclusion criteria will be provided to 
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the aforementioned mental health services.  Potential participants will be told about the study by a 
familiar clinician (for example, their community psychiatric/learning disability nurse) and should they 
be interested, provided with a participant information sheet.  Information sheets will be specific to 
the focus and field test groups, and will be available for participants and welfare guardians.  Focus 
group information sheets will invite the person with ID and their paid or family carers to participate 
in focus groups.  Contact information and reply slips with freepost envelops will be provided with 
information sheets, allowing potential participants to notify their interest in the study.  In 
accordance with the Adults with Incapacity (Scotland) Act), consent will be taken from those who 
have capacity to consent to take part in research and wish to participate in the study.  For those who 
wish to participate but do not have such capacity, consent will be sought from their nearest relative 
or welfare guardian/attorney.  Information sheets will be provided to the participant’s nearest 
relative or welfare guardian/attorney detailing the purpose of the study and what participant would 
entail.   Following consent, information regarding participant level of ID and current psychosis status 
will be sought from appropriate clinicians. 
Measures  
Psychotic Symptom Rating Scales (PSYRATS;  Haddock et al., 1999) 
 The PSYRATS consists of an auditory hallucinations scale comprising of 10 items, and 
a delusions scale comprising of six items.  Probing questions are provided for each 
item, which is scored on a 0-4 point scale.  Individual scoring criteria are provided for 
each item.  See Appendix 9 for PSYRATS Interview Schedule.   
Psychosis screen for adults with ID 
Design  
A between groups design will be employed, with the above scales administered to each group.   
Research Procedures 
An item pool will be generated from existing psychosis screens and diagnostic criteria (see 
Appendices 5 and 9).  It will then be discussed by two focus groups; consisting of a mix of adults with 
ID and their family member or support worker.  At least half of the people in each group will have an 
ID.  The focus group will be facilitated by the trainee clinical psychologist, with additional support 
provided by another trainee or member of the clinical team.  The facilitator will help the groups 
reach consensus of relevant items and concepts. The focus groups will last up to two hours and will 
inform refinement of the items, ensuring they are accessible to people with ID.  A draft scale will 
then be developed and reviewed by experts in the field (i.e. clinicians and researchers of psychosis in 
ID).  The resulting schedule, along with the PSYRATS, will then be administered to the field test 
group, along with their family member or support worker, in a one-to-one interview with the trainee 
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clinical psychologist.  Those with an ID and psychosis from the field test group will then be 
interviewed with the new scale on a second occasion one to two weeks later (to allow examination 
of test re-test reliability).  Analysis of the psychometric properties of the resulting schedule will then 
be conducted.    
Data Analysis  
Descriptive statistics will be used to investigate the spread of the data.  If the data is parametric, 
discriminant validity will be tested using an independent t-test.  If the data is non-parametric, 
discriminant validity will be tested using a Mann-Whitney test.  Criterion validity will be tested by 
correlating scores of the new scale with scores of the PSYRATS for the non-psychosis group.  Test re-
test reliability will be examined by correlating scores of the new scale from two time points.  If the 
data is parametric, Pearson’s correlation coefficient will be used.  If the data is non-parametric, 
Spearman’s correlation coefficient will be used.  Internal consistency of the psychosis screen for 
adults with ID will be examined using Cronbach’s α (or Cohen’s Kappa).  Sensitivity and specificity 
will be examined through determining threshold scores for the psychosis screen for adults with ID 
which correctly identify those with and without a diagnosis of psychosis.  
Justification of sample size  
Six to ten people in total will be recruited for the focus groups.  A minimum of 12 people will be 
recruited for each psychosis and non-psychosis group.  This sample size has been informed by 
clinicians working with people with ID and psychosis in Greater Glasgow & Clyde, who have 
estimated that there will be approximately 20 people with ID and active psychosis over the 
recruitment period (which will last up to seven months).   Similar numbers have been found to be 
sufficient for the development of a depression screening tool for use in adults with ID (Cuthill et al., 
2003) which is now routinely used, and thus should also be adequate for a psychosis screening tool.   
Power calculation 
In order to provide further justification of the proposed sample size and to determine whether the 
results will be indicative of a true clinical difference, the statistical software ‘G*Power 3.0.10’ was 
used to perform a sensitivity analysis.  G*Power requires information to be input regarding the type 
of test conducted and parameter values from that test. In this case, selections were: ‘t tests’, 
‘ Means: Difference between two independent means (two groups)’, and ‘Sensitivity: Compute 
required effect size – given α, power, and sample size’. A power of 0.8 or more provides an 80% 
chance of detecting an effect if one genuinely exists. Therefore, a power of ≥0.8 will be used to 
signify a clinically relevant finding.  
For a pilot study, it is recommended that a sample size of 12 participants per group is employed 
(Julious, 2005).  Therefore, for difference in psychosis scores between the two groups, the 
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parameters: α err prob (0.05), power 1-β err prob (0.8), sample size group 1 (12), sample size group 
2 (12) were entered into G*Power, and an effect size was calculated to be 1.0.  Therefore, recruiting 
a sample of 12 participants per group will yield a large effect size of 0.6.   
Settings and Equipment  
A private, quiet room will be required to conduct focus groups and interviews. Necessary equipment 
includes the aforementioned screening measures and stationary for the focus groups. 
Health and Safety Issues  
Researcher Safety Issues  
Due to the nature of psychosis, the behaviour of participants may be unpredictable, with the 
potential for outbursts of distress or aggression directed toward the researcher.  All interviews will 
be conducted within a day centre or NHS clinical areas, ensuring that support can be obtained 
quickly from other members of staff.  Furthermore, those individuals most likely to become 
impulsive are likely to be residing in inpatient care, where their interviews would take place.  As 
such, staff would be able to advise on the individual’s ability to participate and would be able to 
provide additional support if required.  Such clinical areas will be equipped with alarms and the 
researcher will adhere to local GG&C guidelines.   An additional trainee clinical psychologist or 
member of the clinical team will attend the focus groups, providing the researcher with additional 
support, should it be required.  For further details, see Appendix 4.1.   
Participant Safety Issues  
It is possible that participants may become upset when discussing distressing psychotic experiences.  
However, both focus groups and interviews will be conducted by a trainee clinical psychologist who 
is experienced in working in clinical settings with patients who at times become distressed.  The 
interviewer will therefore be able to use their skills to risk assess and contain any such distress.  The 
additional trainee clinical psychologist or member of the clinical team attending the focus groups will 
ensure that should a participant become upset or wish to take a break, one person will be available 
to support them while the other can continue to facilitate the group.  For further details, see 
Appendix 4.1.   
Ethical Issues 
There are two pertinent ethical issues that may arise within this study.  Firstly, due to the nature of 
both ID and psychosis, it is possible that potential participants may not have capacity to consent to 
participate.  In order to ensure that only those who have capacity and wish to participate are 
recruited, the trainee clinical psychologist will assess capacity to consent, in accordance with the 
Adults with Incapacity (Scotland) Act.  Secondly, it is possible that participants may become 
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distressed while discussing the nature of their illness.  In order to insure participants are fully 
informed, it will be made clear during the consent process that: i) participants may become upset; ii) 
participants are free to withdraw from the study at any point; and iii) withdrawing will have no effect 
on the care they receive.  If a participant becomes overly distressed but does not ask to end their 
participation, the trainee clinical psychologist may choose to do so if it is deemed to be in the best 
interests of the participant.  In such scenarios, the interviewer will use their clinical training to 
alleviate participant distress.  For further details, see Appendix 4.1.   
Ethical approval will be sought from a research ethics committee specialising in learning disability 
(e.g. Scotland A REC).  
Financial Issues  
 Freepost envelopes and paper for participant information sheets and consent forms 
 Stationary for focus groups: flip chart, pens, paper. 
 Refreshments for focus groups: tea/coffee, juice, biscuits. 
See Research Costs form in Appendix 4.2. 
Timetable  
Task Estimated length of time to completion Estimated start date Estimated completion date Draft proposal   16/03/15  Final proposal   17/0715  Research and Development submission 
Up to 4 weeks  Mar 2015 Apr 2015 
Ethics Submission 2-3 months Apr/May 2015 June/July 2015 Generate items list 3 weeks July 2015 July 2015 Recruit and run focus group Up to 6 weeks Aug 2015 Sep 2015 Make scale/ expert review Up to 6 weeks Sep 2015 Oct 2015 Final refinement Up to 3 weeks Jan 2016 Jan/Feb 2016 Recruit and field test Up to 4 months Feb 2016 May 2016 Test psychometric properties Up to 2 months May 2016 June 2016 
 
Practical Applications  
The resulting screening measure may help with the identification of psychotic symptoms in adults 
with ID, potentially aiding diagnoses and allowing changes in the severity of illness to be measured.   
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The results of the study will be written in the trainee clinical psychologist’s thesis.  The results will 
also be published in scientific journals and presented at meetings and conferences.  Results of the 
study will also be disseminated to the participants who are interested in receiving them.   
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Appendix 4.1 
WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
 
HEALTH AND SAFETY FOR RESEARCHERS 
 
1. Title of Project Development of a psychosis screening tool for use in 
adults with intellectual disabilities 
2. Trainee Dr Amanda Muir 
3. University Supervisor Dr Alison Jackson 
4. Other Supervisor(s) Dr Moira Phillips 
5. Local Lead Clinician Dr Moira Phillips 
6. Participants: (age, group or sub-
group, pre- or post-treatment, etc.) 
Adults aged ≥16 with intellectual disability and a 
diagnosis of psychosis, not currently in episode. 
Paid or family carers of adults aged ≥16 with intellectual 
disability and a diagnosis of psychosis. 
Adults aged ≥16 with intellectual disability without a 
diagnosis of psychosis. 
Adults aged ≥16 with intellectual disability and a 
diagnosis of psychosis, currently in episode. 
 
7.    Procedures to be applied  
(e.g., questionnaire, interview, etc.) 
 
 
 
Two separate focus groups will be conducted. 
Questionnaires will be administered to the ID group with 
active psychosis on two occasions (between one to two 
weeks apart). 
8.    Setting (where will procedures be 
carried out?) 
General 
 
Focus groups will be carried out at an NHS location, such 
as a hospital, resource centre or day centre. 
Interviews will be carried out at NHS inpatient units, 
resource centres or day centres.  If day centres are not 
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NHS buildings, local health and safety policies will be 
checked and discussed with the study supervisor prior to 
arranging focus groups.  This will ensure health and 
safety procedures are equivalent to NHS procedures. 
 ii) Are home visits involved
  
No 
9.    Potential Risk Factors Identified  
      (see chart) 
 
 
 
 
1) It is possible that participants of the focus group may 
be upset while discussing symptoms that they find 
distressing. 
2) It is possible that participants who are completing 
questionnaires may become upset by discussing 
symptoms that they find distressing. 
3) Furthermore, for those participants experiencing 
psychosis, they may as a result present with impulsive, 
irrational or unpredictable behaviour, and/or have poor 
emotional control.   
10.   Actions to minimise risk (refer to 9) 
 
 
 
 
 
 
 
 
Firstly, with regards to each point, it is reasonable to 
expect that some individuals may become upset whilst 
discussing a topic which they find distressing.  However, 
it is not expected that the nature of the topics would 
produce distress of a significant level.   
In order to minimise any possible distress, participants 
would be made aware that: 
Participation is of a voluntary nature, and they can 
withdraw from the study at any time. 
Participants can take as many breaks as necessary 
Participants can choose to be accompanied by a carer or 
support worker with whom they feel safe. 
Participants are under no obligation to discuss anything 
that they do not wish to disclose 
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The interviewer is a trainee clinical psychologist who has 
experience with adults with mental ill health, both with 
and without intellectual disability.  The interviewer also 
has experience of working with adults with intellectual 
disabilities both in individual and group settings, with 
and without their carers.  The interviewer is experienced 
in working with people who are or have become upset, 
distressed or angry.  As such, the interviewer is able to 
identify risk and determine the best course of action, for 
example, acknowledging the distress and allowing space 
for the individual, using breaks where necessary, 
containing or minimising distress, and where necessary 
ending sessions.  An additional trainee clinical 
psychologist or member of the clinical team will attend 
the focus groups.  This will allow one person to provide 
one-to-one support to any individual if they become 
distressed, while the facilitator can remain with the rest 
of the group.  
 
Furthermore, it is probable that the individuals most 
likely to become impulsive, irrational or distressed will 
be those currently experiencing psychosis to an extent 
which has necessitated their stay in inpatient care.  As 
such, staff/nurses would be able to advise whether the 
individual is well enough to participate on a given day, 
will be in the vicinity if the individual becomes distressed 
(to a level requiring their assistance).  Within such 
inpatient settings, personal alarms or panic buttons will 
be available should they be required, and the 
interviewer will be aware of the process, according to 
local NHS health and safety policy. 
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For any participants who become distressed, the trainee 
clinical psychologist will seek their consent to inform 
their carer/relative/nurse of their distress.   
 
 
 
Trainee signature:       Date: 13/07/15  
 
University supervisor signature:      Date:   
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Appendix 4.2 
 
 
 RESEARCH EQUIPMENT, CONSUMABLES AND EXPENSES  
 
 
Trainee …Amanda Muir………………………………………………………………………       
 
Year of Course Second……………………………….    Intake Year…2013………….. 
 
Please refer to latest stationary costs list (available from student support team) 
 
 Item  Details and Amount Required  Cost or Specify if to Request to Borrow from Department  Stationary   
1 x box of labels at £3.17 1x box of A4 Envelopes at £9.01 1x box of A5 Envelopes at £8.52 500x B&W Print 1 sheet at £0.05 
   Subtotal: £45.70  Postage   
100X Freepost costs per letter at £0.62    Subtotal: £62.00  Photocopying and Laser Printing (includes cost of white paper)  
     Subtotal: £0.00  Equipment and Software  
Flip chart     Subtotal: £0.00  Measures   
PSYRATS    Subtotal: £0.00  Miscellaneous Refreshments for focus groups (tea, coffee, water, juice, biscuits)   
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  Pens  Subtotal: £20.00 Total  £127.70  
For any request over £200 please provide further justification for all items that contribute to a high total 
cost estimate. Please also provide justification if costing for an honorarium: 
 
Trainee Signature…………………………………… …   Date……………………… 
 
Supervisor’s Signature ………………………………..    Date ……………………… 
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Appendix 5 – DC-LD Diagnostic criteria 
IIB3. 1X Schizophrenic/delusional episode 
A The symptoms/signs must not be a direct consequence of other psychiatric disorders (e.g. 
dementia, delirium, depressive episode, manic episode, mixed affective episode), 
prescribed or illegal drugs or alcohol or physical disorders such as thyroid dysfunction. 
B The criteria for schizoaffective episode are not met.  (Hierarchically, schizoaffective episode 
takes precedence over schizophrenic/delusional episode.) 
C One of item groups 1, 2 or 3 must be present: 
1 One of the following symptoms must be present on most days for at least two weeks: 
a Third person auditory hallucinations (hallucinatory voices discussing the person 
among themselves) 
b Hallucinatory voices from some part of the body 
c Impossible/fantastic delusions (delusions are culturally inappropriate and completely 
impossible, for example, being able to communicate with aliens) 
d Thought insertion or withdrawal or broadcasting; or thought echo; or delusions of 
control, influence or passivity (clearly referred to body or limb movements or specific 
thoughts, actions or sensations); or delusional perception; or hallucinatory voices 
giving a running commentary. 
2 One of the following symptoms is present for most of the time during a one-month 
period, or some time every day for at least one month (a longer timescale, in view of 
the lesser diagnostic significance of these symptoms): 
a Delusions are not mood congruent (delusions cannot be explained by the person’s 
religious, cultural and environmental background) 
b Hallucinations that are not mood congruent – these may occur in any sensory 
modality. 
3 Two of the following symptoms must be present on most days for at least two weeks, 
although may change in intensity and type from day to day: 
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a Delusions, that are not mood congruent (delusions cannot be explained by the 
person’s religious, cultural and environmental background) 
b Hallucinations that are not mood congruent – these may occur in any sensory 
modality. 
c Catatonic symptoms, for example stupor, posturing, waxy flexibility, negativism 
d ‘Negative’ symptoms, where there is definitive evidence that these are a change from 
the individual’s premorbid state/baseline functioning, for example apathy, loss of 
adaptive skills, impairment of goal-directed behaviour, flattening or incongruity of 
emotional responses 
e Disordered form of thought, where there is definitive evidence that this is a change 
from the individual’s premorbid state. 
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Appendix 6 – Ethical approval and amendments 
Appendix 6.1 Scotland A REC approval
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Appendix 6.2 NHS GG&C R&D approval 
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Appendix 6.3 Ayrshire & Arran R&D approval 
 
96 
 
    
97 
 
 
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
Appendix 6.4 Details of substantial amendment 
The original study proposal consisted of three stages as shown below.  However, due to 
time constraints a substantial amendment was made to the methodology, whereby two 
steps were omitted (shown in boxed italics).  
 
Inclusion criteria 
Focus groups 
 Adults aged ≥16 with a mild to moderate ID who have reasonable verbal 
communication i.e. are able to express themselves, and diagnosis of 
psychosis. 
 Family or paid carers of adults with mild to moderate ID who have a 
diagnosis of psychosis and wish to take part in the focus group. 
 
Pilot group 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, a diagnosis of psychosis, and are currently experiencing 
psychosis. 
 
Field test groups 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, a diagnosis of psychosis, and are currently experiencing 
psychosis. 
 Adults aged ≥16 with a mild to moderate ID, who have reasonable verbal 
communication, and do not have a diagnosis of psychosis. 
 Adults aged ≥16 without ID, who have reasonable verbal communication, a 
diagnosis of psychosis, and are currently experiencing psychosis. 
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Appendix 6.5 NHS GG&C approval of substantial amendment 
Dear Dr A. Muir, 
  
R&D Ref: GN15CP484    Ethics Ref: 16/SS/0004 
Investigator: Dr Amanda Muir 
Project Title: Development of a psychosis screening tool for use in adults with 
intellectual disabilities 
Protocol Number: V10; 18/03/16 
Amendment: Substantial Amendment 1 (07/04/16) 
Sponsor: NHS Greater Glasgow and Clyde 
  
I am pleased to inform you that R&D have reviewed the above 
study's Amendment 1 (07/04/16) and can confirm that Management Approval is still 
valid for this study. 
  
  
Reviewed Documents:                                                            
 Version 
  
Dated Ethics Approval Letter   04/05/16 
Notice of Substantial Amendment Form   0704/16 
GP Letter 3 21/03/16 
Proposal 10 18/03/16 
PIS-4 Field Test ID psychosis group 7 18/03/16 
Recruitment Information for Health Care Team 5 21/03/16 
WGNR LD Field Test Group Consent Form 4 18/03/16 
WGNR PIS-3 LD field Test Group 5 18/03/16     I wish you every success with this research project.     Kind regards   NHS GG&C R&D West Glasgow Ambulatory Care Hospital Dalnair Street Glasgow G3 8SW   Tel: +44 (0)141 232 1815 Generic email for PR team: RandD.PRTeam@ggc.scot.nhs.uk        Web: www.nhsggc.org.uk/r&d   Please note that R&D operates a paperlite electronic record system. Please submit study documents via email.  
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Appendix 6.6 NHS A&A approval of substantial amendment 
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Appendix 6.7 Details of non-substantial amendment 
Dr Moira Phillips and Dr Fiona Cuthill were added to the list of investigators, allowing them to 
conduct interviews. 
 
Appendix 6.8 NHS GG&C approval of non-substantial amendment 
Dear Dr A. Muir, 
 R&D Ref: GN15CP484    Ethics Ref: 16/SS/0004 Chief Investigator: Dr Alison Jackson Project Title: Development of a psychosis screening tool for use in adults with intellectual disabilities Protocol Number: V10; 18/03/16 Amendment: Minor Amendment (20/05/2016) Sponsor: NHS Greater Glasgow and Clyde  
I am pleased to inform you that R&D have reviewed the above study's Amendment and can confirm that Management Approval is still valid for this study. 
Reviewed Documents: Version Dated Rec’d 
Notification of minor amendment --- 20/05/16 30/05/2016 Participant information sheet 4 (learning disability psychosis field test group) 8 20/05/16 30/05/2016 Participant information sheet 5 (learning disability non-psychosis field test group) 5 20/05/16 30/05/2016 Participant information sheet 3 (nearest relative /guardian or welfare attorney) 6 20/05/16 30/05/2016 
 
The Amendment includes also an addition of two researchers: Dr Moira Phillips and Dr Fiona Cuthill, who will be carrying out some of the interviews. 
I wish you every success with this research project. 
  Kind regards NHS GG&C R&D West Glasgow Ambulatory Care Hospital Dalnair Street Glasgow G3 8SW   Tel: +44 (0)141 232 1815 Generic email for PR team: RandD.PRTeam@ggc.scot.nhs.uk        Please note that NHS GG&C R&D now operates an electronic record system and that only electronic submissions are now accepted
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Appendix 6.9 NHS A&A approval of non-substantial amendment  
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Appendix 7 – Development of GPS-ID 
Appendix 7.1. Focus group interview schedule 
This interview schedule sets out a broad structure and additional questions will be asked depending on the direction of the conversation. 
1. Introduction and thanks for coming 
a. Go over consent 
b. Lay out plan for group i.e. ice breaker, important info 
2. Ice breaker – ask to introduce the person they have brought with them (or person next to them if they did not bring a carer/relative) 
3. Important info 
a. Confidentiality (and audio recording) 
b. What to do if upset/not needing to disclose what you don’t want others to know 
c. Breaks/toilets 
d. Fire exits 
4. Group rules 
a. Confidentiality (again) 
b. Respecting others/not talking over each other 
c. What rules the group want to add? 
5. Introducing the topic 
a. Psychosis describes lots of different symptoms and experiences.  Some common experiences that people with psychosis have are: hearing 
voices that other people cannot hear; seeing things that other people cannot see; feeling worried that other people are trying to harm 
them; believing things that other people say are impossible.  Some people also find it much harder to do the things they can normally do, 
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like going out with friends or doing their housework.  Some people can find it hard to think properly, and can feel very confused.  This can 
make it hard for them to talk to other people. 
b. I’m interested in finding out about your experiences.  Maybe we can start by making a list of the experiences you have had, then we can 
talk about them all a bit more.  Has anybody had any of the experiences I just mentioned?  Which ones? Additional prompt: what do you 
think is the hardest experience to cope with?  Use prompts from table below to query symptoms that have not been mentioned. 
c. After constructing list, group words into symptom clusters (based on focus group response) and discuss each group i.e. this group describes 
hearing voices, can you tell me a bit more about what that is like?  How does it make you feel?  What do you do when it happens?  How 
might people know this is happening to you? What makes these experiences worse? What helps you cope with these experiences?   
i. To carers: What do notice in person you support? 
ii. Specifically, for voices: What are the voices like? Do you know what they are saying? Do they say nasty things?  Are the voices ever 
nice?  Do you ever talk to them?  What is that like?  Do other people notice when you talk to the voices?  What would they think? 
Do you ever try to ignore the voices?  What happens when you try this? How do the voices make you feel?  Do you feel scared of 
the voices?  If you can hear the voices, and your family or carer is trying to speak to you, what does this feel like?  What do 
carers/family notice? 
d. Repeat c. for each group identified and refer to prompts in table  
e. You’ve told me about lots of different experiences, like i.e. hearing voices or thinking other people are talking about you.  I’ve used the 
word ‘psychosis’ to describe these symptoms.  Have you heard of the word ‘psychosis’?  What do you think it means? Do you use it?  What 
other words do you use to describe all of these experiences? What words do carers use? [make list of suggested words] 
f. Overall, how do/have these experiences affect your life?  How would your life be different if you no longer had/have these experiences? 
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Symptom Prompt questions 
1. Present most days for at least 2 weeks 
A Third person auditory 
hallucinations (hallucinatory voices 
discussing the person among 
themselves) 
Do you hear voices that other people can’t hear? 
Do you hear someone talking to you when no-one is there? (Clarify this is not the TV, radio or people 
walking past etc.).  
 
 
B Hallucinatory voices from some part of 
the body  
We’ve talked about hearing voices, where do you think the voices are coming from? Have you 
ever thought that the voice was coming from a part of your body (other than inside your head)? 
C Impossible/fantastic delusions 
(delusions are culturally inappropriate 
and completely impossible, for example, 
being able to communicate with aliens) 
Do you ever think you can do things that other people say are impossible?  For example, 
thinking you have super powers?  Or thinking you can talk to aliens?  Or thinking you have the 
power to make people do anything you want? 
D Thought insertion Do you worry that other people are putting thoughts in to your head? 
Do you worry that your thoughts are not your own? 
Do you ever feel like your thoughts don’t belong to you? 
or withdrawal Do you ever worry that someone has taken your thoughts out of your head? 
Have you felt like someone has stolen your thoughts/ideas/what you have been thinking? 
or broadcasting; Do you worry that other people can hear your thoughts and you don’t want them to? 
Do you worry that people can read your mind? 
Do you worry that people know what you are thinking? 
or thought echo; Do you ever hear your thoughts being repeated out loud? 
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Have you heard another voice repeat your thoughts? 
Do you feel like there is an echo in your head? 
or delusions of control, influence or 
passivity (clearly referred to body or 
limb movements or specific thoughts, 
actions or sensations); 
Have you ever felt that someone else is controlling you/your feelings, your thoughts/ how you 
are behaving? 
Have you thought that your thoughts, feelings and behaviours have not been your own? 
 
or delusional perception; Some people have an experience where something normal happens, but they think it has a 
special meaning, or is a special sign.  For example, someone notices that it has started raining, 
and they think this is a sign that they need to save the world; or they see a green traffic light and 
think that this means they are the king 
or hallucinatory voices giving a running 
commentary 
Do you hear a voice/s that talks about everything you do while you are doing it? 
Do you hear a voice constantly talking about what you are doing? 
2. One of the following symptoms is present for most of the time during a one-month period, or some time everyday for at least one month (a 
longer timescale, in view of the lesser diagnostic significance of these symptoms). 
A Delusions are not mood congruent 
(delusions cannot be explained by the 
person’s religious, cultural and 
environmental background) 
See 1.C 
B Hallucinations that are not mood 
congruent – these may occur in any 
sensory modality. 
 
Do you ever see things that other people can’t see?  What kind of things have you seen?  Did 
you know that other people couldn’t see them?  How did seeing them make you feel? 
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3. Two of the following symptoms must be present on most days for at least two weeks, although may change in intensity and type from day to 
day: 
A Delusions, that are not mood 
congruent (delusions cannot be 
explained by the person’s religious, 
cultural and environmental background) 
See 1.C 
B Hallucinations that are not mood 
congruent – these may occur in any 
sensory modality. 
See 2.B 
C Catatonic symptoms, for example 
stupor, posturing, waxy flexibility, 
negativism 
Have you felt that you have slowed down/that you are moving much more slowly than usual, or 
even staying in the same place and not moving at all, even when other people ask you to move? 
D ‘Negative’ symptoms, where there is 
definitive evidence that these are a 
change from the individual’s premorbid 
state/baseline functioning, for example 
apathy, loss of adaptive skills, 
impairment of goal-directed behaviour, 
flattening or incongruity of emotional 
responses 
 
Do you ever notice a change in the things you can normally do? So, not being able to do things 
as well as normal, or not being able to do them at all? For example, not being able to do the 
daily activities you can normally do, like going for a shower, making your breakfast, cleaning 
your house or doing your food shopping?  
Do you ever notice a change in your motivation/wanting to do things you normally want to do?  
For example, not wanting to go to work/college/day centre, or to meet up with friends? 
Do you notice a change in the way you normally feel?  For example, feeling like you don’t care about 
things?  Feeling a bit numb? Maybe not feeling as happy/excited/angry/upset as you normally would 
about things? 
E Disordered form of thought, where 
there is definitive evidence that this is a 
Have you felt like your thoughts were all mixed up so that when you spoke, you didn’t make 
sense to people? 
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change from the individual’s premorbid 
state. 
 
Have there been times you have felt like you’ve had lots of ideas going around in your head? 
Have other people felt like it’s been hard to understand, because you’ve switched between different 
topics/talking about different things?  
Have there been times when you’ve spoke really fast, without stopping?  Did other people notice this was 
different from how you usually speak? 
Have there been times when people that know you well have not been able to understand what you are 
talking about (and this has been unusual)? 
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Appendix 7.2 Focus group excerpts 
One Participant described being kept awake at night by voices that she thought were coming from 
vans driving past her house at night.  She described sleeping in her wardrobe to try to block out the 
noise.   
Participant 1: Haha, I know it sounds daft but… but, eh, naw… ah, cos, it was during the night and 
whenever bugging me, it was going roon aboot and I was trying to shut it off.  So that’s what I was 
trying to dae, but. 
Support worker 1: Because you could hear the, the voices in the vans didn’t you? 
Participant 1: Oh huh  
Interviewer: The voices in the vans? 
Support worker 1: White vans I think, if I can recall from (nurse) 
Interviewer: Can you tell me a bit more about what the voices in the vans were? 
Participant 1: Uh 
Support worker 1: They were talking about you weren’t they?  
Participant 1: Och, they were calling me Cows an that, whore, uh, umpteen things but. 
 
Another participant seemed to have ambivalent feelings about hearing voices.  Later in the 
conversation, the participant began to experience auditory hallucinations telling her not to talk to 
the group. 
Interviewer: So when you, when you heard the voice telling you what to do… it sounds like from 
what [Support worker 2] is saying, sometimes you would get annoyed by it? 
Participant 2: Yes 
Interviewer: But you said before that sometimes it made you happy… so… was there someone else, 
were they nice to you sometimes? 
Participant 2: Yeah 
Interviewer: Yeah? Can you remember what kind of nice things they used to say? 
Participant 2: How you keeping 
Interviewer: Ok, they’d ask how you’re keeping? 
Participant 2: Yeah 
…………………………………………………………………………………………………………………………………………………… 
Support worker 2: Do you hear anything [Participant 2], in your head? 
Participant 2: Aye 
Support worker 2: What’s it saying? Can you tell us? 
Participant 2: Just keep quiet 
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Interviewer: Ok, so it’s telling you not to talk about it? 
Participant 2: Uhuh.  Keep it quiet 
Interviewer: Just now? 
Participant 2: Uhuh.   
 
Participant 3’s mother and Community Learning Disabilities Nurse (CLDN) talked about how she 
would not recognise her mother when she was unwell. 
Interviewer: And who does she think you are? 
Mother: She thinks I’m either an aunty or I’ve kidnapped her, one of the two 
CLDN: She’s made comments before about “your face has melted”.  That was a long time ago, 
remember when in [inpatient unit] she was saying things like that.  You canny be ma mum your face 
has melted, ma mums face has’ne. 
 
Participant 3 talked about voices which she believed were interfering with her body at night and 
stopping her from breathing.  She frequently used a word (possibly a neologism) which she was 
unable to define ‘cirtle’.  Later in the conversation, her mother pointed out that her eyes were 
shifting when she did not believe what her mother was saying.  
Participant 3: They’re just quiet and they’re tucked away interfering with my throat and I feel my 
neck sore and everything an they’re piercing doon at the top but it’s still interferring.  Somebody’s 
still interfering. Doing things to my human self eh body. 
Interviewer: Ok 
Participant 3: And my human self body is my body, my neck, my neck at the back and my throat at 
the front and they’re breathing’s cutting air, dead, into death, they’re putting a big heavy, heavy 
heavy lasting, it’s in my chest and it’s sitting. This heavy weight on top of my chest 
Interviewer: So it’s like a heavy weight on top of your chest? 
Participant 3: Aye. 
Interviewer: And it’s hard to breath? 
Participant 3: It’s no breathing 
……………………………………………………………………………………………………………………………………………………………. 
Mother: If I wasn’e breathing I wouldn’t be here [Participant 3] and neither would you {says to 
Interviewer watch the (Participant 3’s) eyes] aye they wouldn’e be.  That’s when she’s no believing 
you, did you see the eyes? 
Interviewer: Mhmm 
Mother: Mhmm. Shifty. 
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Appendix 7.3 Expert input 
The expert panel stated that most people do not report what they are experiencing.  They described 
the observations they have made of people with ID and psychosis while working in a Specialist 
Learning Disabilities inpatient unit. 
 
Behaviours 
Distracted, person doesn’t seem to be in the moment 
Person turns their head as if responding to something unseen i.e. nurse is talking to patient and 
patients is looking above nurses head or to the side 
Sudden agitation and no obvious stimulation 
Complaining about excessive noise (when there is none) 
Starting to cry or becoming distressed – spontaneous, no noticeable trigger or cause – appears to be 
responding to a hallucination 
Person becomes distressed when watching t.v. – thinks that a t.v. programme is based on their life  
Person shows no facial expression - distress is only apparent through their disjointed conversation 
Not sleeping – I’m not tired 
Throwing shoes and personal objects at the wall  stating that there is someone in the wall 
Talking to staff then looking away and laughing at something else 
Person wears excessive make-up – change from usual 
Gorging on food (continuous eating/not chewing) but only when food placed in front of them, do not 
seek it out 
Requiring help with eating and drinking 
Shadow boxing 
Eye blinking/twitching head 
Self-care neglect  requiring more prompts than usual 
Standing motionless in shower or stripping and standing motionless 
 Not taking usual cues e.g. in shower but does not start to wash self 
Putting t-shirt on back to front 
Listening to music/t.v./headphones more often to drown out auditory hallucinations 
Talking to phone, talking to self 
reacting to normal sights and sounds oddly, such as changes in light or noises from pipes 
Standing in the shower for a very long time  possibly to block out sensations and sounds 
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Strange beliefs/delusions 
Person makes odd statements e.g. ‘I’ve won Britain’s got talent’; ’I’m in the CIA’; ‘I’ve won a car’; ‘If I 
come out of my bedroom the cutting machines are going to get me‘ 
Delusions based on events in the news 
Beliefs about having a job in the inpatient unit after helping out with a chore  
Patient might not present at distressed but narrative is deluded 
Rocking back and forwards, restless pacing 
Focus on famous/infamous people 
Delusion of being covered in wasps 
Believing that they themselves are the devil 
Being taunted – hearing voices calling them names 
Believing people are watching or staring at them 
Reporting that they cannot sleep because bugs are biting them  
 
Suspicious behaviour/statements 
‘You’re writing lies’ 
Worrying that telling other people about their experience will put those people in danger 
Not feeling safe because others will try to harm them 
Believing insects are in food or medication 
 
Visual hallucinations 
Person states seeing unusual things e.g. Sir Lancelot, mounted police, woman in the wall, man 
standing outside, little boy etc. 
Seeing animals when there are none 
 
Change in personality 
Unusual personality traits 
Labile mood: hysterical laughing  crying  aggressive  quiet  sad 
Unusually aggressive, disproportionate responses with no triggers 
Stripping, running around naked, destructive behaviour 
Impulsive behaviour 
Violent behaviour – linked to delusional beliefs 
Change in personality from good manners to inappropriate  
Overly sexualised behaviour and speech content  
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Appendix 7.4 Expert feedback 
Comments on self-report subscale 
 Start by asking more open questions about how the person is feeling, before asking more 
specific questions that are scored, e.g. “Has anything been bothering or worrying you 
recently?”. 
 Use more open questions and prompts to elicit responses before providing the examples, e.g. 
“Has anyone been picking on you or getting at you?”.  Using the examples first might 
close the person down, or they might response with the example they have just heard.  
 Auditory hallucination examples - voices talking to each other about the person are probably the 
most common type of hallucination, and voices giving commands are also common in psychosis, 
as is a voice giving a running commentary on what the person is doing.  
 Questions and examples are complex and a lot to remember – recommend asking a specific 
question after the example, e.g. “Have you ever heard noises or voices when there is nobody 
around?”. 
 Too many examples for each question.  
 Delusion question – do not think this describes what a delusion is and may lead to confusion.  
 Perhaps more focus on the erroneous or absurd aspects of this experience.   
 Recommend not using a screening item for negative symptoms. 
 Consider whether people will understand the word “experience” – perhaps use the word 
feel/felt/thing, e.g. “Everyone with psychosis feels different”, and “The first thing I want to ask 
you about is…”. 
 Good idea to give examples – in the first section, the easiest examples to understand (in terms of 
complexity of language) are provided first and increase in difficulty.   Recommend following 
easydifficult example order for all three questions.  Person more likely to understand 
shortest/most concrete examples first. 
 The scale of distress - 'How much' is a difficult concept.  Recommend using a visual aid to 
support the person to answer these questions.   
 
Comments of informant rating-subscale 
 Start by asking more open questions/prompts about how the person, e.g. “Any strange 
experiences like hearing voices or seeing things that other people don’t?”.  
 Add to list of questions – Is the person suspicious of other people?  
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 In the questions, as well as the TV, consider including phone and radio. And add in these objects 
referring to the person, giving messages, giving instructions 
 Person talking to self - need to distinguish from soliloquy, rehearsing things, repeating nice 
things. 
 Question re change in person’s sexual behaviour - this is a mania question rather than 
schizophrenia. To capture mania, other more common items would be needed.  Recommend 
removing this question.   
 Too many items - most of them are not specific to psychosis which may lead to high numbers of 
false positives. 
 Consider providing a reminder that questions 14-18 refer to changes that do not need to have 
taken place in only the past two weeks.  
 Question 13 re switching topic in conversation - the ability to appropriately signal a topic shift, is 
like the ability to undertake conversational repair, a higher level language skill. And even people 
with a mild LD have some level of communication difficulty, most likely in this sort of area. So in 
this client group, the question may have less validity. 
 
General comments on administration of tool 
 Two weeks is a short period of time and could miss active symptoms of psychosis – recommend 
increasing to 4 weeks. 
 Recommend developing a glossary of items to facilitate administration. 
 Make clear who would administer the scale – consider that concepts and language are abstract 
so would need to determine that the person can operate at this level. 
 Time scale - even people with mild LD tend to struggle with time concepts.  Recommend that the 
clinician uses an event to anchor the time frame over which symptoms are being asked about.   
 Provide a simple explanation of what psychosis is. 
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Appendix 8 – GPS-ID 
Glasgow Psychosis Screening Tool (GPS-ID) 
 
Section A – self-report  
I would like to ask you/and your relative/ worker some questions about how you have been feeling 
over the last four weeks.  The questions I’m going to ask are about something called psychosis.  
Everyone’s experience of psychosis is different, but there are a few problems that most people 
experience, like seeing or hearing things that other people can’t see and hear.  There are no right or 
wrong answers to these questions, I just want to find out how you have been feeling.  If you like, 
your relative/worker can help you answer. 
   Prompts: 
 Can you tell me how have you been feeling recently?  Has anything been bothering or worrying you?  Has anything strange or unusual happened to you recently?  Has anything happened that you’ve found difficult to talk about or understand?  
1. Do you hear voices or sounds that only you can hear?  Other people like your relative/ worker can’t hear them.  This is not about hearing your own voice when you are speaking or when you are thinking.    Has anything like this happened to you?  Can you tell me about it? Your relative/ worker can help you if you like.  Prompts:  Can you think clearly?  Has anyone been reading your mind?  Has anyone been picking on you or getting to you?  Has the T.V., radio or phone been bothering you?   If you’d like, I can give you some examples of things that have happened to other people? Remember that everyone’s experiences are different  Examples:  Jane hears voices in her head that talk about her; sometimes they call her nasty names.   Mark hears a voice in his head that tells him what to do; sometimes it tells him not to speak to his support workers.   Alice hears voices shouting at her from outside, but no one is there.  Thomas hears a voice in his head that talks to him, sometimes it is nice and asks him how he is feeling.  Claire hears a voice that talks about what she is doing; for example, it will say “Claire is washing the dishes”.  John hears a voice in his head telling him that other people are talking about him; it tells him not to trust them. 
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 How upsetting has this been for you in the last four weeks? ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. Evidence of an auditory hallucination No =0 Yes, little or no distress=1 Yes, very distressing =2  
2. Now I’d like to ask if you see things that only you can see? Other people like your relative/ worker can’t see them.  Has anything like this happened to you?  Can you tell me about it? Your relative/ worker can help you if you like.  Prompts:  Has anyone been watching you?  Have you seen anything that has scared you?  If you’d like, I can give you some examples of things that have happened to other people? Remember that everyone’s experiences are different Examples:  Jane sees a man standing outside her house watching her, but no one else can see the man.   Mark sometimes sees a little boy and an old woman in his house, but no one else can see them.  Alice sometimes sees people that look like zombies walking around; she feels really scared when this happens.  Thomas sometimes thinks he can see a man following him, this happens more when it’s dark.  Claire sometimes sees her granddad waving at her; she knows that he died a long time ago but she feels happy when she sees him.  John sometimes sees animals like cats and dogs, but his family say they can’t see them.    How upsetting has this been for you in the last four weeks? ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. Evidence of a visual hallucination No =0 Yes, little or no distress=1 Yes, very distressing =2   
3. Do you believe or think things that your family/ worker say can’t be true?  Has anything like this happened to you?  Can you tell me about it? Your relative/ worker can help you if you like.  
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Prompts:  How do other people behave to you?  Are you suspicious of anyone?  If you’d like, I can give you some examples of things that have happened to other people? Remember that everyone’s experiences are different Examples:  Jane sometimes thinks that aliens have stolen her brain.  Mark sometimes thinks he is a spy, like James Bond.    Alice sometimes thinks that things happening on a T.V. programme or in the news are about her.  Thomas tells people that he has a new job working in a shop, but his support workers tell him this isn’t true.  Thomas gets really upset about this.  Claire sometimes thinks that someone is trying to kill her; she worries that if she tells her family they will be in danger too.  John sometimes believes that his family is not really his family; he will tell people ‘that’s not my mum’.   How upsetting has this been for you in the last four weeks? ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. ……………………………………………………………………………………………………………………………………………………….. Evidence of a visual hallucination No =0 Yes, little or no distress=1 Yes, very distressing =2  
 
Section B – carer observations  
Now I’d like to ask your relative/ worker some questions about how you have been over the past 
four weeks. 
 Have you noticed any changes in the person’s usual behaviour?  Have you noticed any odd or unusual behaviour that you couldn’t understand?  Can you tell more about this?  Has the person developed any strange or new beliefs, unusual for them?  Can you tell me about these?  Has the person had any strange experiences like hearing voices or seeing things that other 
people do not? 
 
During the last four weeks…  No/  Never Sometimes Always  / A lot 1. Has the person appeared distracted or as though they were listening to something others could not see?   0 1 2 2. Has the person reacted oddly to sights and sounds they would normally tolerate?  For example, have they been scared when lighting in the room has changed or they have heard water 
0 1 2 
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trickling in the radiators? 3. Have you noticed the person turning up the T.V. or radio really loud or spending a long time in the shower as though trying to block out other sensations? 
0 1 2 
4. Have you noticed the person becoming withdrawn?  Perhaps asking for quiet time or talking to people less?  0 1 2 5. Have you noticed the person becoming distressed, agitated, scared or upset when there has been no observable reason for this? 
0 1 2 
6. Have you noticed the person becoming distressed, agitated, scared or upset when in a noisy environment or when watching the T.V., listening to the radio, or when holding their phone (but not making a call)? (Clarify T.V./radio content was not upsetting). 
0 1 2 
7. Has the person thought that the T.V., radio or phone are referring to them, giving them messages or giving them instructions?     0 1 2 8. Has the person been talking to themselves?   0 1 2 9. Have you noticed the person talking to someone who isn’t there, or talking to the T.V. or, radio or to their phone when they haven’t made or received a call? 
0 1 2 
10. Has the person said anything strange or impossible?  For example, that they have stopped breathing, they have been kidnapped, or that aliens are listening to their thoughts?  
0 1 2 
11. Has the person said something plausible that you know is untrue?  For example, that they have just had an operation or that their purse has been stolen? 
0 1 2 
12. When the person is talking to you, have you noticed that sometimes they are not making any sense? 0 1 2 13. When the person is talking to you, have they switched between different topics so that it is hard to follow what they are talking about? 
0 1 2 
14. When you are talking to the person, have you noticed their eyes shifting to the side or their head twitching?  0 1 2 15. Has the person been suspicious of other people? 0 1 2 16. Has the person had problems sleeping? For example, have they complained of not being able to sleep because of hearing voices or feeling things on their skin, such as bugs crawling on them or biting them? 
0 1 2 
17. Have you noticed a change in the person’s self-care skills? For example, have they been less able to wash themselves as well as they normally would? Have they put their clothes on back to front?  Have they worn much more or much less make-up or hair gel than usual? Have they needed more self-care prompts?   
0 1 2 
18. Have you noticed a change in how the person usually eats and drinks?  For example, have they gorged on food, gulping it down without chewing it properly? Have they seemed distracted and eaten less than usual?  Have they needed more help with eating and drinking than usual? 
0 1 2 
19. Have you noticed a change in the person’s personality?  For example, have they been more aggressive, irritable, upset, distressed or quiet than usual?  Have they appeared to do things 
0 1 2 
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more slowly than usual?   20. Have you noticed any other change causing concern?......................................................................................... ………………………………………….....................................................................…………………………………………............................................................... 
0 1 2 
 
Scoring system 
Subscale Score Section A – Self-report Hallucinations subscale = question 1 + question 2  Delusions subscale = question 3  Total self-report = question 1 + question 2 + question 3 (range 0-6)    Section B – Informant ratings Total informant rating = Sum of questions 1-20 (range 0-40)    Total score = section A + section B (range 0- 46)   
A total score of ≥4 yields a sensitivity of 90% and specificity of 100% 
The GPS-ID is not a diagnostic tool.  Any Individual meeting or exceeding this score should receive 
further assessment.  It is possible that the cut-off score can be met without a positive score on the 
self-report scale – it is imperative that such scores be interpreted with caution and individuals 
receive further assessment to rule out other possible causes of the observed behaviours.  
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Very Upset OK or a little upset 
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GPS-ID: interviewer instructions for use 
 
The GPS-ID is not a diagnostic tool.  Any individual meeting or exceeding the cut-off score of ≥4 
should receive further assessment. 
 
This screening tool is designed to be completed by a clinician competent in the assessment of 
mental health difficulties, e.g. a psychologist or a psychiatrist.  It should be completed with both the 
individual and a relative or worker who knows them well, and has observed their behaviour over the 
past four weeks.  Section A is designed to encourage the individual to report their experiences, with 
help from their relative/worker if necessary.  Section B asks their relative/ worker to rate how often 
the individual has displayed a range of behaviours.   
 
Section A (questions 1-3) 
This section is designed to encourage the individual to self-report any symptoms they have been 
experiencing over the past four weeks. To help the individual think about this time-frame, try to 
establish an anchor event that occurred four weeks ago (for example going to a birthday party) and 
ask them to think about how they have felt since then.  All writing in plain text should be read aloud 
to the individual, substituting ‘person’ and ‘relative’ etc. for the appropriate name, e.g.  “I’d like to 
ask you and your mum some questions…”.  Use the first list of prompts to encourage the individual 
to talk about how they have been feeling, before moving on to the specific questions 1-3.  For 
questions 1-3, an initial question is followed by several prompt questions.  Although the prompts in 
questions 1 and 2 are designed to elicit reporting of hallucinatory experiences, it is possible they may 
cause the person to discuss experiences of delusions, and vice versa, with the prompts in question 3.  
If this occurs, use the information the individual supplies to complete the relevant question.  It is not 
necessary to ask all the prompt questions the assessor should use clinical judgement to guide them.  
If the individual is struggling to understand the question and prompts, move on to the examples.  It 
is not necessary to read through every example, but they should be read in the order in which they 
appear.  After each example ask “Has anything like that happened to you?”.   Always ask the initial 
question and prompts before reading the examples.   
For reports of hallucinations, check that these cannot be explained by other sources, for example 
hearing a neighbours’ T.V. or someone walking past outside.  For reports of delusions, check that 
these are not developmentally appropriate beliefs, such as having imaginary friends.  Record the 
person’s hallucination and/or delusional experiences and ask how upsetting they have found these 
to be, using the visual aid to help them answer.  Clinical judgement should be used to decide 
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whether there is evidence of true hallucinatory or delusional experience, and rate according to level 
of distress reported by the person and their relative/ worker.   
 
Section B (questions 1-20)  
This section is designed to help the relative/worker report behaviours they have witnessed over that 
past four weeks that may be indicative of psychosis.  The initial prompts should be used to 
encourage the relative/worker to speak more broadly about any unusual behaviour or changes they 
have noticed, before asking them to rate the specific questions.  The relative/ worker is asked to rate 
how often the behaviours outlined in questions 1-17 have been present during the past four weeks.  
Questions 17-20 refer specifically to any changes that the carer has noticed in the individual’s 
behaviour.  These changes do not have to have occurred in the past four weeks, and may have been 
noticeable over the last few months.  If the carer has noticed changes but these are known to be due 
to a physical illness they should be rated as ‘No/Never’. 
Glossary of terms and instructions for use 
For all items, do not rate if they can be explained by other psychiatric disorders, drug or alcohol use, 
physical illness or sensory impairments. 
1. Appearing distracted/listening to something others could not see The person struggles to concentrate on those around them and may appear to focus on empty space as though listening to some unseen entity speaking to them.  2. Reacting oddly to sights and sounds they would normally tolerate Does the person appear scared or agitated by sights or sounds that usually have no effect?  Ensure not due to sensory issues.    3. Blocking out other sensations  Check that person is not turning up the T.V. or radio to drown out noise from other objective sources.  Do not rate if they have a known hearing impairment.      4. Becoming withdrawn Is there evidence that this is a change from the individual’s usual functioning, for example apathy, loss of adaptive skills, impairment of goal-directed behaviour, flattening or incongruity of emotional responses.  Rate as ‘2’ if present for most days for at least two weeks.  Do not rate if there is a clear explanation, such as a life event precipitating low mood.     5. Distressed, agitated, scared or upset when there has been no observable reason Check that there is no obvious reason for distress, or whether it may be a delayed reaction to another event.  Did it seem as though the person was responding to something that others could not see or hear.  6. Distressed, agitated, scared or upset due to noisy environment/T.V./radio/phone Clarify that T.V./radio content was not distressing.  Check whether person understands T.V. shows/characters are not real e.g. do they think that a character actually died or that another character is an actual murderer.   
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 7. Concern that the T.V., radio or phone are referring to them  As above, ensure that person understands T.V. programmes are not real.  Probe to ascertain if there is a logical reason as to why the individual thinks the T.V. was referring to them, e.g. they share a similarity with a character or the show is set in the city they live in.      8. Person has been talking to themselves If this is the person saying their thoughts out loud, rehearsing things or repeating nice things to themselves it should be scored as ‘0’.   9. Talking to someone who isn’t there, or to the T.V., radio or phone  10. Saying strange or impossible things  Check the person’s level of conviction, do they continue to believe these things despite evidence to the contrary.  Do not rate if they can be explained by the person’s religious, cultural and environmental background.  11. Saying something plausible that is untrue Check there is not a rational reason for why the individual thinks this.  If it has been a misunderstanding rate as 0.  If the individual believes it to be true despite there being no misunderstanding or no evidence, rate as 1 or 2.  12. Person is not making sense when talking Is there evidence that this is different from the person’s usual level of functioning?  Rate if there is evidence of making up new words, breaks, adding in information, or being tangential in the train of thought.  13. Person switching between different topics when talking As above.  14. Person’s eyes shifting to the side or their head twitching  Rate as ‘0’ if this is known to be due to a visual or other sensory impairment.    15. Suspicious of other people Only rate this symptom as present if there are no rational grounds for the person’s suspicions.  It is important to consider that people with learning disabilities can be vulnerable to bullying and abuse.  16. Problems sleeping If the person reports being kept awake by voices or noise, check these are not from neighbours or outside etc.  If the person has been observed to have problems sleeping but has not reported why, check they have not experienced any recent physical illness or pain that might account for this problem.      17. Changes in the person’s self-care skills Rate as 0 if due to physical ill health.   18. Change in how the person usually eats and drinks Rate as 0 if due to physical ill health.   19. Change in the person’s personality 
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Check that changes cannot be explained by physical ill health or pain.  20. Other change in behaviour Rate behaviour which is a change from the person’s usual behaviour and cannot be explained by a rational cause, or physical illness. 
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 Appendix 9 – PSYRATS 
 
The Psychotic Symptom Rating Scales 
 
Interview Schedule 
 
Gillian Haddock 
Version 2009 
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AUDITORY HALLUCINATIONS  
  1. Frequency    
Probing questions  
How often have you heard your voices over the last week?   Thinking about the last week, what has it been like?’’ e.g. every day, all day long etc.”    
Scoring criteria:  
  0 Voices not present or present less than once a week (specify frequency if present)  1 Voices occur for at least once a week  2 Voices occur at least once a day  3 Voices occur at least once an hour  4 Voices occur continuously or almost continuously i.e., stop for only a few seconds or minutes  
  
  2. Duration    
Probing questions  
When you have heard your voices over the last week, how long have they lasted?  Have they lasted for a few seconds, minutes, hours, all day long for example....?”    
Scoring criteria:  
  0 Voices not present  1 Voices last for a few seconds, fleeting voices  2 Voices last for several minutes  3 Voices last for at least one hour  4 Voices last for hours at a time  
    3. Location     
Probing questions  
When you have heard your voices over the last week, where did they sound like they were happening?    Did they sound like they were inside your head and/or outside your head? Whereabouts do your voices sound like they are coming from?    
Scoring criteria:  
0 No voices present  
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1 Voices sound like they are inside head only  2 Voices outside the head, but close to ears or head.  Voices inside the head may also be present.  3 Voices sound like they are inside or close to ears and outside head away from ears  4 Voices sound like they are from outside the head only  
    4. Loudness    
Probing questions   
How loud are your voices?  Are they louder than my voice, about the same loudness, quieter or just a whisper?    
Scoring criteria:  
  0 Voices not present  1 Quieter than own voice, whispers.  2 About same loudness as own voice  3 Louder than own voice  4 Extremely loud, shouting       5. Beliefs regarding the origin of voices    
Probing questions  
What do you think has caused your voices?   Are the voices caused by factors related to you, or due to other people or factors?  Are your voices caused by your mental health problems or illness?    How much do you believe that your voices are caused by (add interviewee’s contribution) on a scale from 0-100 with 100 being that you are totally convinced, have no doubts and 0 being that it is completely untrue?    
Scoring criteria:  
  0 Voices not present  1 Believes voices to be solely internally generated and related to self  2 Holds a less than 50% conviction that voices originate from external causes  3 Holds 50% or more conviction (but less than 100%) that voices originate from external causes  4 Believes voices are solely due to external causes (100% conviction)       6. Amount of negative content of voices  
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Probing questions  
Do you think that your voices have said unpleasant things or negative things over the last week?  How much of the time do the voices say these types of unpleasant or negative items?    
Scoring criteria:  
  0 No unpleasant content  1 Occasional unpleasant content  2 Minority of voice content is unpleasant or negative (less than 50%)  3 Majority of voice content is unpleasant or negative (50% or more)  4 All of voice content is unpleasant or negative    
 7. Degree of negative content    
Probing questions  
Can you tell me a bit about what you have heard your voices saying over the last week?  Can you give me some examples of the things you have heard this week?    
Scoring criteria:  
  0 Not unpleasant or negative  1 Some degree of negative content, but not personal comments relating to self or family e.g. swear words or comments not directed to self, e.g. “the milkman’s ugly”  2 Personal verbal abuse, comments on behaviour e.g. “shouldn’t do that or say that”  3 Personal verbal abuse relating to self-concept e.g. “you’re lazy, ugly, mad, perverted”   4 Personal threats to self e.g. threats to harm self or family, extreme instructions or commands to harm self or others and personal verbal abuse as in (3)  
      8. Amount of distress    
Probing questions   
Have you found your voices to be distressing over the last week?   How much of the time have they caused you distress over the last week?    
Scoring criteria:    0 Voices not distressing at all  1 Voices occasionally distressing, majority not distressing (<10%)  
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2 Minority of voices distressing (<50%)  3 Majority of voices distressing, minority not distressing (≥ 50%)  4 Voices always distressing      9. Intensity of distress    
Probing questions  
Over the last week when your voices have been distressing, how distressing has that been?  Thinking about the worst distress you could feel, over the last week, how have your voices compared to that? For example, has it been slightly, moderately distressing etc.?    
Scoring criteria:    0 Voices not distressing at all  1 Voices slightly distressing  2 Voices are distressing to a moderate degree  3 Voices are very distressing, although interviewee could feel worse  4 Voices are extremely distressing, feel the worst he/she could possibly  
feel  
  
 10. Disruption to life caused by voices    
Probing questions  
How much disruption have the voices caused to your life over the last week?  Can you tell me how the voices stopped you from working or doing any other daytime activity that you wanted to do?   How much have they interfered with your relationships with friends and/or family?  How much have they prevented you from looking after yourself, e.g. bathing, changing clothes, etc.?    
Scoring criteria:  
    0 No disruption to life, able to maintain social and family relationships (if present)  
  1 Voices cause minimal amount of disruption to life e.g. interferes with concentration although able to maintain daytime activity and social and family relationships and be able to maintain independent living without support.  
  2 Voices cause moderate amount of disruption to life causing some disturbance to daytime activity and/or family or social activities.  The interviewee is not in hospital although may live in supported accommodation or receive additional help with daily living skills.  
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3 Voices cause severe disruption to life so that hospitalisation is usually necessary.  The interviewee is able to maintain some daily activities, self-care and relationships whilst in hospital.  The interviewee may also be in supported accommodation but experiencing severe disruption of life in terms of activities, daily living skills and/or relationships.  4 Voices cause complete disruption of daily life requiring hospitalisation.  The interviewee is unable to maintain any daily activities and social relationships.  Self-care is also severely disrupted.  
    11. Controllability of voices    
Probing questions  
What control had you had over your voices over the last week?  
How much control have you had over your voices when they happened over the last week?   
Can you get rid of, dismiss or bring on your voices?”  
  
Scoring criteria:   
0 Interviewee believes they can have control over the voices and can always bring on or dismiss them at will  
  1 Interviewee believes they can have some control over the voices on the majority of occasions  
  2 Interviewee believes they can have some control over their voices approximately half of the time  
  3 Interviewee believes they can have some control over their voices but only occasionally.  The majority of the time the interviewee experiences voices which are uncontrollable  
  4 Interviewee has no control over when the voices occur and cannot dismiss or bring them on at all.  
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DELUSIONAL BELIEFS  
  1. Amount of preoccupation with delusions     
Probing questions  
Over the last week, how much time have you spent thinking about your beliefs about …… [insert client’s beliefs]?    
Scoring criteria:  
  0 No delusions, or delusions which the interviewee thinks about less than once a week.  1 Interviewee thinks about beliefs at least once a week.  2 Interviewee thinks about beliefs at least once a day.  3 Interviewee thinks about beliefs at least once an hour.  4 Interviewee thinks about delusions continuously or almost continuously.  
    
  2. Duration of preoccupation with delusions    
Probing questions  
When you have thought about any of your beliefs (i.e. [insert interviewee’s beliefs] …) over the last week, how long do they tend to stay in your mind? - Few seconds/minutes/hours, etc.?    
Scoring criteria:  
  0 No delusions  1 Thoughts about beliefs last for a few seconds, fleeting thoughts  2 Thoughts about delusions last for several minutes  3 Thoughts about delusions last for at least one hour  4 Thoughts about delusions usually last for hours at a time  
  
  3. Conviction    
Probing questions  
 
At the moment, do you have any doubts about any of your beliefs, for example do you sometimes wonder whether they are real or not? (Go through each belief in turn).     How much do you believe in…[insert belief/beliefs]?  Can you estimate this on a scale from 0 – 100, where 100 means that you are totally convinced by your beliefs and 0 being that you are not convinced at all?  
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Scoring criteria:  
  0 No conviction at all  1 Very little conviction in reality of beliefs, less than 10%  2 Some doubts relating to conviction in beliefs, between 10-49%  3 Conviction in belief is very strong, between 50 – 99%  4 Conviction is 100%    
      4. Amount of Distress    
Probing questions   
Have your beliefs about [insert interviewee’s beliefs] caused you distress over the last week? How much of the time have they caused you distress over the last week?    
Scoring criteria:  
  0 Beliefs never cause distress  1 Beliefs cause distress on the minority of occasions.  2 Beliefs cause distress on less than 50 % of occasions  3 Beliefs cause distress on the majority of occasions when they occur between 51-99% of time  4 Beliefs always cause distress when they occur  
    5. Intensity of Distress      
Probing questions  
Over the last week, when you have felt distressed by your beliefs about [insert interviewee’s beliefs] how severe does this feel?” Have you felt slightly, distressed, moderately distressed etc..    
Scoring criteria:  
  0 No distress  1 Beliefs cause slight distress  2 Beliefs cause moderate distress  3 Beliefs cause marked distress  4 Beliefs cause extreme distress, couldn’t be worse  6. Disruption to life caused by beliefs    
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Probing questions  
In what way have your beliefs caused disruption for you over the last week?  In what way have they stopped you working or carrying out a day-time activity?  In what way have they interfered with your relationships with family or friends?  In what way have they interfered with your ability to look after yourself, e.g. washing, changing clothes, etc.?    
Scoring criteria:  
  0 No disruption to life, able to maintain independent living with no problems in daily living skills.  Able to maintain social and family relationships (if present)  1 Beliefs cause minimal amount of disruption to life, e.g. interferes with concentration although able to maintain daytime activity and social and family relationships and be able to maintain independent living without support.  2 Beliefs cause moderate amount of disruption to life causing some disturbance to daytime activity and/or family or social activities.  The interviewee is not in hospital although may live in supported accommodation or receive additional help with daily living skills.  
  3 Beliefs cause severe disruption to life so that hospitalisation is usually necessary.  The interviewee is able to maintain some daily activities, self-care and relationships whilst in hospital.  The interviewee may also be in supported accommodation but experiencing severe disruption of life in terms of activities, daily living skills and/or relationships.  
  4 Beliefs cause complete disruption of daily life requiring hospitalisation.  The interviewee is unable to maintain any daily activities and social relationships.  Self-care is also severely disrupted.  
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AUDITORY HALLUCINATIONS RATING SCALE SCORE 
SHEET 
     
Briefly describe experiences for rating:  
                          
1.  FREQUENCY…………………………………………………………....  
   
2.  DURATION……………………………………………………………...  
  
3.  LOCATION…………………………………………………………….... 
  
4.  LOUDNESS……..………………………………………………….…….  
  
5.  BELIEFS RE-ORIGIN OF VOICES………………………………… 
  
6.  AMOUNT OF NEGATIVE CONTENT OF VOICES………… 
  
7.  DEGREE OF NEGATIVE CONTENT…………………….……… 
 
8.  AMOUNT OF DISTRESS……………………………………………  
  
9.  INTENSITY OF DISTRESS…………………………………………. 
  
10.      DISRUPTION…………………………………….…………………………  
  
11.       CONTROL……………………………………………………………….…  
 
TOTAL AUDITORY HALLUCINATIONS SCORE        
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 DELUSIONS RATING SCALE SCORE SHEET  
    
Briefly describe experiences for rating:  
  
    
1.  AMOUNT OF PREOCCUPATION…………………………….…  
    
2.  DURATION OF PREOCCUPATION…………………………….  
  
3.  CONVICTION…………………………………………………….……. 
 
4.  AMOUNT OF DISTRESS…………………………………………… 
    
5.  INTENSITY OF DISTRESS…………………………………………. 
  
6.  DISRUPTION……………………………………………………………  
  
  
TOTAL DELUSIONS SCORE              
 
 
  
  
  
  
  
  
  
